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General Procedures
Dry solvents were freshly distilled under argon from an appropriate drying agent before use. 
Bis(cyclooctadiene)iridium(I) tetrakis(3,5-bis(trifluoromethyl) phenyl) borate (abbreviated as 
Ir(cod)2BArF), Bis(1,5-cyclooctadiene)iridium(I) tetrafluoroborate (abbreviated as Ir(cod)2BF4, 1,2-
Bis[bis(pentafluoro-phenyl)phosphino]ethane (abbreviated as dppFe) were purchased from Aldrich. 
Other bisphosphines were purchased from Aldrich or Strem-Chemicals. All other reagents used 
were bought from Aldrich, Alfa Aesar, TCI or Acros and used without further purification.
All reactions dealing with air- and moisture-sensitive compounds were carried out in oven-dried 
reaction flask under argon atmosphere with dry solvents. The abbreviation “rt” refers to reactions 
carried out approximately at 23 °C. Reaction mixtures were stirred using Teflon-coated magnetic 
stirring bars. Reaction temperatures were maintained using Thermowatch-controlled silicone oil 
baths. Thin-layer chromatography (TLC) was performed on silica gel plates and components were 
visualized by observation under UV light, and / or by treating the plates with p-anisaldehyde or 
phosphomolybdic acid solutions, followed by heating. Flash chromatography was carried out on 
silica gel unless otherwise stated. Dryings were performed with anhydrous Na2SO4 or MgSO4. 
Concentration refers to the removal of volatile solvents via distillation using a Bchi rotary 
evaporator followed by residual solvent removal under high vacuum. NMR spectra were recorded in 
CDCl3, at 300 MHz (Varian), 400 MHz (Varian) or 500 MHz (Varian). Carbon types and structure 
assignments were determined from DEPT-NMR. NMR spectra were analyzed using MestreNova© 
NMR data processing software (www.mestrelab.com). 1,3,5-Trimethoxybenzene was used as 
internal standard. The following abbreviations are used to indicate signal multiplicity: s, singlet; d, 
doublet; t, triplet; q, quartet; dd, double doublet; ddd, doublet of doublet of doublets; td, triple 
doublet; dt, doublet of triplets; dq, doublet of quartet; m, multiplet; br, broad. Mass spectra (ESI-MS) 
were acquired using IT-MS Bruker AmaZon SL at CIQUS and also using chemical ionization (CI) 
electron impact (EI), or electrospray ionization (ESI) at the CACTUS facility of the University of 
Santiago de Compostela. The reactions were monitored by TLC. Enantioselectivities were 
determined in an Agilent HPLC 1100 Series with Chiralpak IA, IB, IC, IA3 or OZ-H analytical 
columns.
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Optimization of the reaction conditions 
Table S1. Optimization of the reaction conditions[a]
entry 1 R [M] (X mol%) L (y mol%) Yield (%)[b]
1 1a NEt2 Ir(cod)2BArF (5) dFppe (5) 2a, 91
2 1a NEt2 Ir(cod)2BArF (5) P(C6F5)3 (10) 2a, <5
3 1a NEt2 Ir(cod)2BArF (5) dppe (5) 2a, 32
4 1a NEt2 Ir(cod)2BArF (5) dppb (5) 2a, 62
5 1a NEt2 Ir(cod)2BArF (5) rac-Binap (5) 2a, 80
6[c] 1a NEt2 Ir(cod)2BF4 (5) dFppe (5) 2a, 75
7 1a NEt2 [Ir(cod)Cl]2 (2.5) dFppe (5) 2a, –
8[d] 1a NEt2 Rh(cod)2BArF (5) dppe (5) 2a, <2
9[d] 1a NEt2 Rh(cod)2BArF (5) dFppe (5) 2a, <2
10 1a NEt2 Rh(cod)2BArF (5) rac-Binap (5) 2a, <2
11 1b Pyr Ir(cod)2BArF (5) dFppe (5) 2b, 44
12 1u OEt Ir(cod)2BArF (5) dFppe (5) 2u, –
13 1v OH Ir(cod)2BArF (5) dFppe (5) 2v, –
14 1c Me Ir(cod)2BArF (5) dFppe (5) 3c, 32
15 1w Ph Ir(cod)2BArF (5) dFppe (5) 3w, 33
[a] Conditions: 1 was added to a solution of complex [M] (x mol%) and L (y mol%) in dioxane and the mixture 
was heated at the indicated temperature. [b] Isolated yield. [c] The same result was obtained when the 
catalyst was generated from [Ir(cod)Cl]2 (2.5 %), dFppe (5 %) and AgBF4 (5 %). [d] The same result was 
obtained at 140 ºC. 
Hypothesis for the formation of products of type 3
The results obtained with the methyl and phenyl ketone derivatives 1c and 1w (Table S1, entries 14 
and 15) would suggest that, for these substrates, an endo-cyclization to afford intermediates like II 
and III would be preferred, eventually leading to products of type 3 after a reductive elimination. The 
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reason for the formation of endo product 3 is not clear, but might be related to the weaker 
coordinating ability of the keto with respect to the amide group
Synthesis of the substrates for catalysis
General procedure A for preparation of 1,6-diene precursors 1a, 1b, 1d, 1e, 1f, 1g, 1j, 1h and 
1i (exemplified for the synthesis of 1f). 
5-Hydroxy-N-methoxy-N-methylpentanamide (S1)
Prepared following a procedure described by Flick and coworkers.[1] 
AlMe3, (60 mL, 120 mmol, 2.0 M in hexane) was added dropwise to a stirred solution of 
N,O-dimethylhydroxyl-amine hydrochloride1 (11.7 g, 120 mmol) in dry CH2Cl2 (26 mL) at 
0 °C. (CAUTION: The reaction is very exotermic). The mixture was stirred for 20 min at 0 
°C and D-valerolactone (8.0 g, 80 mmol) of was added dropwise. After stirring at 0 °C for 
20 min, the mixture was diluted with CHCl3 (125 mL) and then HCl (aq) (15 mL, 0.1 N) was added 
dropwise at 0 °C. The mixture was stirred for 1 h, the organic phases were separated, dried, filtered, 
and concentrated under reduced pressure to give 5-hydroxy-N-methoxy-N-methylpentanamide 
(12.9 g, 99% yield) as a white solid. The NMR data was consistent with previous characterization.
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5-((tert-Butyldimethylsilyl)oxy)-N-methoxy-N-methylpentanamide (S2)
Prepared following a modified procedure described by Stork and coworkers.[2] 
imidazole (13.2 g, 194 mmol), tert-butyldimethylsilyl choride (17.3 g, 115 mmol) and 4-
dimethyl aminopyridine (117 mg, 0.96 mmol) were sequentially added to a solution of 
5-hydroxy-N-methoxy-N-methylpentanamide (12.9 g, 80 mmol) in CH2Cl2 (275 mL, 
0.29 M). The solution was stirred for 15 minutes, water (10 ml) was added and the 
reaction mixture was extracted with Et2O (3 x 10 mL). The combined organic extracts were washed 
with water and brine, dried and evaporated. The crude was purified by column chromatography on 
silica gel (1:1 Et2O – hexane) to obtain the desired product as colorless oil (21.0 g, 95% yield). The 
characterization analysis was consistent with the previous data.2
7-((tert-Butyldimethylsilyl)oxy)-2-methylheptan-3-one (S3) [3] 
iPrMgBr (98 mL, 98 mmol), 1.0 M) was added dropwise to a solution of 5-((tert-
butyldimethylsilyl)oxy)-N-methoxy-N-methylpentanamide (S2, 9.0 g, 32.6 mmol) in Et2O
(220 mL, 0.15 M) at -78 ºC. The reaction was allowed to warm to rt and stirred 
overnight. Then Rochelle’s Salt (sat) (50 mL) was added at 0 ºC, the organic phse was 
separated and subsequently washed with NH4Cl (sat) (250 mL), water (200 mL) and
brine (200 mL). After extraction with Et2O (3 x 280 mL), the combined organic extracts were dried 
and evaporated to yield a crude residue that was purified by column chromatography on silica gel 
(1:8 Et2O – hexanes) to obtain the desired product (S3) as colorless oil (8.4 g, 57% yield) The NMR  
data is consistent with that previously described in literature.3 1H NMR (300 MHz, CDCl3): δ 3.56 (t, 
J = 6.2 Hz, 2H), 2.54 (p, J = 6.9 Hz, 1H), 2.42 (t, J = 7.2 Hz, 2H), 1.63 – 1.52 (m, 2H), 1.50 – 1.41 
(m, 2H), 1.03 (d, J = 6.9 Hz, 6H), 0.84 (s, 9H), -0.01 (s, 6H).13C NMR (75 MHz, CDCl3): δ 214.64 
(C), 62.95 (CH2), 40.78 (CH), 40.12 (CH2), 32.39 (CH2), 26.01 (CH3), 20.33 (CH2), 18.32 (CH3), -
5.26 (CH3). MS (ESI): ([M+H]+) 259.2.
tert-Butyldimethyl((6-methyl-5-methyleneheptyl)oxy)silane (S4) 
Sodium tert-butoxide (3.84 g, 40 mmol) was added to a suspension of 
methyltriphenylphosphonium bromide (16.2 g, 45.4 mmol) in benzene (90 mL, 0.2 M).
The mixture was refluxed for 4 hours, allowed to cooled down to rt and a solution of 7-
((tert-butyldimethylsilyl)oxy)-2-methylheptan-3-one, (S3, 4.7 g, 18.18 mmol) in benzene 
(10 mL) was added. The mixture was stirred for 12 hours, concentrated and most of the phosphine 
oxide was precipitated by adding cold hexane . After filtration of this oxide and evaporation of the 
solvent, the resulting crude was purified by column chromatography (1:40 Et2O – hexane) to obtain 
desired product as colorless oil (3.9 g, 84 % yield). 1H NMR (300 MHz, CDCl3):  δ 4.77 – 4.66 (m, 
2H), 3.63 (t, J = 6.2 Hz, 2H), 2.31 – 2.16 (m, 1H), 2.04 (t, J = 6.9 Hz, 2H), 1.61 – 1.43 (m, 2H), 1.03 
(d, J = 6.8 Hz, 6H), 0.90 (s, 9H), 0.05 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 156.06 (C), 106.41 
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(CH2), 63.29, (CH2) 34.34 (CH2), 33.86 (CH), 32.87 (CH2), 26.15 (CH3), 24.51(CH2), 22.05 (CH3), -
5.10 (CH3). MS (ESI): ([M+H]+) 257.2
6-Methyl-5-methyleneheptan-1-ol (S5)
TBAF (38 mL, 1 M, 38 mmol) was added to a solution of tert-butyldimethyl((6-methyl-5-
methyleneheptyl)oxy)silane (S4, 3.90 g, 15.2 mmol) in THF (152 mL, 0.1M) at 0 ºC. The 
reaction mixture was allowed to warm to rt and stirred for 30 min. NH4Cl (sat) (20 mL) 
was then added and the layers were separated. The aqueous phase was extracted with 
Et2O (3 x 70 mL) and the combined organic extracts were dried, evaporated and purified by column 
chromatography (1:5 Ethyl acetate – hexane) to yield the desired alcohol as a colorless oil (1.90 g, 
88% yield). 1H NMR (300 MHz, CDCl3):  δ 4.76 – 4.62 (m, 2H), 3.60 (t, J = 6.4 Hz, 2H), 2.32 – 2.14 
(m, 2H), 2.02 (t, J = 7.2 Hz, 2H), 1.62 – 1.43 (m, 4H), 0.99 (d, J = 6.8 Hz, 6H). 13C NMR (75 MHz, 
CDCl3): δ 155.80 (C), 106.43 (CH2), 62.78 (CH2), 34.20 (CH2), 33.75 (CH), 32.64 (CH2), 24.34 
(CH2), 21.92 (CH3). MS (ESI): ([M+H]+) 143.1
6-Methyl-5-methyleneheptanal (S6)
DMSO (2.7 mL, 38.0 mmol) in CH2Cl2 (4.1 mL, 2.5 M) was added dropwise to a solution 
of oxalyl chloride (1.6 mL, 19.0 mmol) in CH2Cl2 (60 mL, 0.18 M) at –78 °C. The reaction 
was stirred for 10 min and then a solution of 6-methyl-5-methyleneheptan-1-ol (S5) (1.5 
g, 10.6 mmol) in CH2Cl2 (7.5 mL, 1.4 M) was added slowly. After 45 min Et3N (7.3 mL) 
was added at –78 °C. After stirring at that temperature for 30 min, the mixture was warmed to rt and 
stirred for 30 min. H2O (10 mL) was then added, the organic phase was separated  and washed with 
HCl (1.0 M  solution), NaHCO3 (sat) and brine. The organic phases was dried and carefully 
concentrated under vacuum at 0 °C. The crude aldehyde was submitted to the next step without 
purification. 1H NMR (300 MHz, CDCl3):  δ 9.78 (t, J = 1.7 Hz, 1H), 4.80 – 4.68 (m, 2H), 2.48 – 2.41 
(m, 2H), 2.27 – 2.17 (m, 1H), 2.06 (t, J = 7.6 Hz, 2H), 1.86 – 1.72 (m, 2H), 1.02 (d, J = 6.9 Hz, 6H).
13C NMR (75 MHz, CDCl3): δ 202.47 (COH), 154.74 (C), 107.22 (CH2), 43.53 (CH2), 33.64 (CH2), 
21.90 (CH), 21.83 (CH3), 20.48 (CH2). 
 
(E)-N,N-Diethyl-8-methyl-7-methylenenon-2-enamide (1f)
Dimethyl (2-(diethylamino)-2-oxoethyl) phosphonate (1.52 g, 6.85 mmol) was added 
dropwise to a suspension of NaH (60 %) (251 mg, 6.28 mmol) in THF (36 mL) at rt. 
The mixture was stirred for 15 minutes before 6-methyl-5-methyleneheptanal (800 
mg, 5.71 mmol) was added dropwise to the mixture. After one hour, water and Et2O 
were successively added and the layers were separated. The organic phase was 
washed with water (2 x 10 mL). The aqueous combined phases were extracted with CH2Cl2 (2 x 10 
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mL) and the combined organic phases were dried and concentrated. Purification of the crude 
residue by flash chromatography on silica gel (1:10 to 1:3 EtOAc: Hexanes) afforded the desired 
product as a colorless oil (907 mg, 67 % yield). 1H NMR (300 MHz, CDCl3): δ 6.92 – 6.75 (m, 1H), 
6.19 – 6.02 (m, 1H), 4.75 – 4.56 (m, 2H), 3.39 – 3.26 (m, 4H), 2.21 – 2.11 (m, 3H), 2.03 – 1.95 (m, 
2H), 1.60 – 1.50 (m, 2H), 1.18 – 1.04 (m, 6H), 1.00 – 0.89 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 
165.79 (C), 155.27 (C), 145.72 (CH), 120.65 (CH), 106.59 (CH2), 42.08 (CH2), 40.73 (CH2), 33.80 
(CH2), 33.64 (CH), 32.16 (CH2), 26.79 (CH2), 21.83 (CH3), 14.84 (CH3), 13.15 (CH3). HRMS (ESI-
TOF): m/z calculated for C15H28NO ([M+H]+) 238.2164, found 238.2165.
(E)-N,N-Diethyl-7-methyleneundec-2-enamide (1a)
This compound was prepared according to the general procedure A using nBuMgBr 
instead of iPrMgBr.1H NMR (300 MHz, CDCl3): δ 6.85 (dt, J = 14.5, 7.0 Hz, 1H), 6.15 
(dd, J = 15.0, 1.6 Hz, 1H), 4.69 – 4.63 (m, 2H), 3.40 – 3.30 (m, 4H), 2.20 – 2.11 (m, 
2H), 2.02 – 1.91 (m, 4H), 1.60 – 1.48 (m, 2H), 1.39 – 1.20 (m, 4H), 1.17 – 1.06 (m, 
6H), 0.85 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 165.86 (C), 149.40 (C), 
145.78 (CH), 120.71 (CH), 109.04 (CH2), 42.13 (CH2), 40.80 (CH2), 35.68 (CH2), 35.49 (CH2), 32.10 
(CH2), 30.02 (CH2), 26.50 (CH2), 22.49 (CH2), 14.89(CH3), 14.00 (CH3), 13.20 (CH3). HRMS (ESI-
TOF): m/z calculated for C16H30NO ([M+H]+) 252.2321, found 252.2322.
(E)-N,N-Diethyl-7-methylocta-2,7-dienamide (1d)
This compound was prepared according the general procedure A using MeMgBr
instead of iPrMgBr. 1H NMR (300 MHz, CDCl3): δ 6.79 (dt, J = 14.5, 7.0 Hz, 1H), 6.13 
– 6.05 (m, 1H), 4.61 – 4.55 (m, 2H), 3.33 – 3.23 (m, 4H), 2.14 – 2.05 (m, 2H), 1.96 –
1.90 (m, 2H), 1.59 (s, 3H), 1.55 – 1.43 (m, 2H), 1.12 – 0.99 (m, 6H). 13C NMR (75 
MHz, CDCl3): δ 165.66 (C), 145.53 (CH), 145.07 (C), 120.62 (CH), 110.12 (CH2), 
41.98 (CH2), 40.64 (CH2), 37.03 (CH2), 31.81 (CH2), 26.16 (CH2), 22.12 (CH3), 14.74 (CH3), 13.05 
(CH3). HRMS (ESI-TOF): m/z calculated for C13H24NO ([M+H]+) 210.1851, found 210.1852.
(E)-N,N-Diethyl-7-phenylocta-2,7-dienamide (1h)
This compound was prepared according to the general procedure A using PhMgBr
instead of iPrMgBr. 1H NMR (300 MHz, CDCl3): δ 7.41 – 7.22 (m, 5H), 6.94 – 6.82 
(m, 1H), 6.16 (dt, J = 15.0, 1.5 Hz, 1H), 5.29 – 5.01 (m, 2H), 3.44 – 3.29 (m, 4H), 
2.53 (td, J = 7.5, 1.2 Hz, 2H), 2.28 – 2.17 (m, 2H), 1.67 – 1.55 (m, 2H), 1.21 – 1.06 
(m, 6H). 13C NMR (75 MHz, CDCl3): δ 165.83 (C), 148.08 (C), 145.55 (CH), 141.16 
(C), 128.33 (CH), 127.41 (CH), 126.16 (CH), 120.90 (CH), 112.68 (CH2), 42.14 (CH2), 40.81 (CH2), 
34.76, (CH2) 31.92 (CH2), 26.93 (CH2), 14.92 (CH3), 13.24 (CH3). HRMS (ESI-TOF): m/z calculated 
for C18H26NO ([M+H]+) 272.2009, found 272.2009.
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(E)-7-Methylene-1-(pyrrolidin-1-yl)undec-2-en-1-one (1b)
This compound was prepared according to the general procedure A using dimethyl 
(2-oxo-2-(pyrrolidin-1-yl)ethyl)phosphonate in the last step.1H NMR (300 MHz, 
CDCl3): δ 6.89 (dt, J = 15.1, 7.0 Hz, 1H), 6.08 (dt, J = 15.1, 1.6 Hz, 1H), 4.72 – 4.64 
(m, 2H), 3.48 (dd, J = 6.7, 3.6 Hz, 4H), 2.23 – 2.13 (m, 2H), 2.05 – 1.90 (m, 6H), 
1.88 – 1.80 (m, 2H), 1.61 – 1.53 (m, 2H), 1.43 – 1.22 (m, 4H), 0.88 (t, J = 7.1 Hz, 
3H). 13C NMR (75 MHz, CDCl3): δ 164.63 (C), 149.14 (C), 145.11 (CH), 121.77 (CH), 108.89 (CH2), 
46.31 (CH2), 45.59 (CH2), 35.51 (CH2), 35.28 (CH2), 31.81 (CH2), 29.84 (CH2), 26.31 (CH2), 25.99 
(CH2), 24.18 (CH2), 22.31 (CH2), 13.83 (CH3). HRMS (ESI-TOF): m/z calculated for C16H28NO 
([M+H]+) 250.2167, found found 250.2165.
(E)-N,N-Diethylocta-2,7-dienamide (1i)
This compound was prepared according to the last two steps of the general 
procedure A using the commercial available hex-5-enal as the aldehyde. 1H NMR 
(300 MHz, CDCl3): δ 6.84 (dt, J = 14.4, 7.0 Hz, 1H), 6.14 (d, J = 15.1 Hz, 1H), 5.82 –
5.65 (m, 1H), 4.99 – 4.88 (m, 2H), 3.34 (dd, J = 16.2, 7.6 Hz, 4H), 2.21 – 2.1 (m, 2H), 
2.08 – 1.98 (m, 2H), 1.56 – 1.44 (m, 2H), 1.18 – 1.05 (m, 6H). 13C NMR (75 MHz, 
CDCl3): δ 165.81 (C), 145.60 (CH), 138.24 (CH), 120.76 (CH), 114.90 (CH2), 42.11 (CH2), 40.78 
(CH2), 33.17 (CH2), 31.82 (CH2), 27.61 (CH2), 14.88 (CH3), 13.18 (CH3). HRMS (ESI-TOF): m/z 
calculated for C12H22NO ([M+H]+) 196.1697, found 196.1697.
(E)-N,N-Diethyl-8-methyl-7-methylenenon-2-enamide (1e)
This compound was prepared according to the general procedure A using iBuMgBr 
instead of iPrMgBr. 1H NMR (300 MHz, CDCl3): δ 6.94 – 6.80 (m, 1H), 6.16 (dd, J = 
15.0, 1.7 Hz, 1H), 4.73 – 4.62 (m, 2H), 3.37 (dq, J = 14.7, 7.2 Hz, 4H), 2.22 – 2.12 (m, 
2H), 1.98 (t, J = 7.7 Hz, 2H), 1.88 – 1.80 (m, 2H), 1.78 – 1.63 (m, 1H), 1.62 – 1.50 (m, 
2H), 1.22 – 1.07 (m, 6H), 0.89 – 0.79 (m, 6H).13C NMR (75 MHz, CDCl3): δ 165.93 
(C), 148.15 (C), 145.85 (CH), 120.76 (CH), 110.57 (CH2), 45.92 (CH2), 42.18 (CH2), 40.85 (CH2), 
35.21 (CH2), 32.18 (CH2), 26.49 (CH2), 26.06 (CH), 22.57 (CH3), 14.95 (CH3), 13.26 (CH3).HRMS 
(ESI-TOF): m/z calculated for C16H30NO ([M+H]+) 252.2320, found 252.2322.
(E)-7-Benzyl-N,N-diethylocta-2,7-dienamide (1g)
This compound was prepared according to the general procedure A using BnMgBr
instead of iPrMgBr. 1H NMR (300 MHz, CDCl3): δ 7.30 – 7.23 (m, 2H), 7.21 – 7.14 (m, 
3H), 6.93 – 6.81 (m, 1H), 6.15 (dd, J = 15.0, 1.3 Hz, 1H), 4.79 (d, J = 19.5 Hz, 2H), 
3.46 – 3.24 (m, 6H), 2.24 – 2.10 (m, 2H), 2.06 – 1.94 (m, 2H), 1.66 – 1.53 (m, 2H), 
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1.21 – 1.09 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 165.86 (C), 148.39 (C), 145.64 (CH), 139.69 (C), 
129.00 (CH), 128.33 (CH), 126.13 (CH), 120.81 (CH), 111.62 (CH2), 43.03 (CH2), 42.15 (CH2), 
40.82 (CH2), 34.91 (CH2), 32.05 (CH2), 26.37 (CH2), 14.93 (CH3), 13.24 (CH3). HRMS (ESI-TOF):
m/z calculated for C19H28NO ([M+H]+) 286.2165, found 286.2165.
(E)-N,N-Diethyl-2-methyl-7-methyleneundec-2-enamide (1j)
This compound was prepared according the general procedure A using S6 and the 
appropriate dimethyl (1-(diethylamino)-1-oxopropan-2-yl)phosphonate instead of 
dimethyl (2-(diethylamino)-2-oxoethyl)phosphonate. 1H NMR (300 MHz, CDCl3): δ 
5.45 (t, J = 7.2 Hz, 1H), 4.67 (d, J = 7.0 Hz, 2H), 3.33 (q, J = 7.1 Hz, 3H), 2.10 –
1.93 (m, 6H), 1.79 (s, 3H) , 1.56 – 1.44 (m, 2H), 1.42 – 1.22 (m, 4H), 1.14 – 1.05 (m, 
6H), 0.87 (t, J = 7.0 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 173.51 (C), 149.62 (C), 132.28 (C), 
129.34 (CH), 108.95 (CH2), 42.61 (CH2), 38.77 (CH2), 35.74 (CH2), 30.05 (CH2), 27.25 (CH2), 27.21 
(CH2), 22.53 (CH2), 14.56 (CH3), 14.06 (CH3), 13.47 (CH3) {NOTE: This latter signal at 13.47 ppm 
corresponds to the methyl group of the amide moiety which, due to the existence of rotamers, can 
only be clearly observed carrying out the NMR at 60 ºC}. HRMS (ESI-TOF): m/z calculated for 
C17H32NO ([M+H]+) 266.2479, found 266.2478.
General procedure B for preparation of indene precursors 1l, 1m, 1n and 1t (exemplified for 
the synthesis of 1m)
1-(2-Bromophenyl)-4-methylpentan-2-one (S7)
(2-Bromobenzyl)magnesium bromide was prepared following a modified 
procedure described by Whitesides et. al.[5] Under an inert atmosphere, 
magnesium turnings (1.1 equiv) were covered with Et2O (0.35 M) and activated 
with iodine and 1,2-dibromoethane. A solution of bromobenzyl-bromide (1 equiv) in Et2O (0.35 M) 
was added dropwise to the activated magnesium. The solution was refluxed for 20 min before being 
allowed to cool down to rt. The resulting solution containing the Grignard reagent (17.2 mmol) was 
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added dropwise to a solution of N-methoxy-N,3-dimethylbutanamide4 (6.88 mmol) at -78 ºC in Et2O 
(46 mL). The reaction was allowed to warm to rt and was stirred overnight. The mixture was cooled 
in an ice-water bath and a solution of Rochelle salt was added. NH4Cl (sat) was added and the 
layers were separated. The aqueous phase was extracted with Et2O and the combined organic 
phases were dried and concentrated to yield a crude residue that was purified by flash 
chromatography (from 1 : 40 to 1 : 10, Et2O: Hexanes) to afford the desired product (S7) as 
colorless oil (1.35 g, 77 % yield). 1H NMR (300 MHz, CDCl3):  δ 7.56 (dd, J = 8.0, 1.3 Hz, 1H), 7.27 
(td, J = 7.4, 1.3 Hz, 1H), 7.20 (dd, J = 7.6, 2.0 Hz, 1H), 7.13 (ddd, J = 7.9, 7.1, 1.9 Hz, 1H), 3.83 (s, 
2H), 2.38 (d, J = 6.9 Hz, 2H), 2.25 – 2.12 (m, 1H), 0.93 (d, J = 6.6, 0.6 Hz, 6H). 13C NMR (75 MHz, 
CDCl3): δ 206.61 (C), 134.87 (C), 132.90 (CH), 131.82 (CH), 128.80 (CH), 127.65 (CH), 125.11 (C), 
51.53 (CH2), 50.55 (CH2), 24.55 (CH), 22.66 (CH3). MS (ESI): ([M+H]+) 255.0 and 257.0
1-Bromo-2-(4-methyl-2-methylenepentyl)benzene (S8)
Methyltriphenylphosphonium bromide (3.35 g, 9.40 mmol) was dissolved in 
benzene (20 mL) under argon. Sodium tert-butoxide (0.83 g, 8.62 mmol) was 
added portion wise to this solution and the mixture was refluxed for 2 hours. 
The yellow solution was allowed to reach rt, the ketone (S7, 3.92 mmol) in benzene (0.2 M) was 
added dropwise and the reaction was stirred overnight. Water (40 mL) and Et2O (40 mL) were 
sequentially added. The layers were separated and the aqueous phase was extracted with Et2O (2 x 
40 mL). The combined organic layers were dried and concentrated. The crude residue was 
dissolved in Et2O, cooled to -78 ºC, and carefully decanted into another flask to separate the 
phosphine oxide (this operation was repeated three times). Combined organic phases were
concentrated and the resulting crude residue was chromatographed (1:40 to 1:20, Et2O : Hexane) to
afford the desired S8 as colorless oil (678 mg, 67% yield) 1H NMR (300 MHz, CDCl3):  δ 7.60 –
7.55 (m, 1H), 7.30 – 7.22 (m, 2H), 7.16 – 7.04 (m, 1H), 4.97 – 4.52 (m, 2H), 3.47 (s, 2H), 2.02 –
1.83 (m, 3H), 0.96 (d, J = 6.2 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ 146.47 (C), 139.44 (C), 132.90 
(CH), 131.29 (CH), 127.88 (CH), 127.38 (CH), 125.33 (C), 112.92 (CH2), 46.23 (CH2), 42.31 (CH2), 
26.28 (CH3), 22.68 (CH3). MS (ESI): ([M+H]+) 253.1 and 255.1
2-(4-Methyl-2-methylenepentyl) benzaldehyde (S9)
nBuLi (6.52 mmol, 2.6 mL, 2.5 M) was added dropwise to a solution of S8 (550 
mg, 2.1 mmol) in THF (2 mL) at -78 ºC. After stirring for 30 min, DMF (0.83 
mL, 10.8 mmol) in THF (0.67 mL) was added dropwise and the reaction was 
allowed to slowly warm to rt. After TLC indicates full conversion, NH4Cl (sat) (5 mL) was added. 
After extraction with Et2O (3 x 10 mL), the combined organic phases were dried and concentrated. 
Purification of the crude residue by flash chromatography on silica gel (Et2O: Pentane 1 : 20) 
afforded the titled aldehyde as colorless oil (222 mg, 51% yield). 1H NMR (300 MHz, CDCl3):  δ 
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10.22 (s, 1H), 7.86 (dd, J = 7.7, 1.5 Hz, 1H), 7.55 – 7.47 (m, 1H), 7.37 (t, J = 7.6 Hz, 1H), 7.25 (d, J
= 7.3 Hz, 1H), 4.86 – 4.35 (m, 2H), 3.69 (s, 2H), 1.96 (d, J = 7.1 Hz, 2H), 1.91 – 1.79 (m, 1H), 0.90 
(d, J = 6.5 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ 13C NMR (75 MHz, cdcl3) δ 192.07 (C), 148.32 (C), 
142.29 (C), 134.43 (C), 133.87 (CH), 131.89 (CH), 130.39 (CH), 127.02 (CH), 113.20 (CH2), 46.58 
(CH2), 38.52 (CH2), 26.19 (CH), 22.58 (CH3). MS (ESI): ([M+H]+) 203.1
(E)-N,N-Diethyl-3-(2-(4-methyl-2-methylenepentyl)phenyl) acrylamide (1m)
Following the procedure for the Horner–Wadsworth–Emmons reaction
(previously exemplified for the synthesis of compound 1f, (see page S7), the 
product was obtained as a white solid. (206 mg, 63%yield). 1H NMR (300 MHz, 
CDCl3):  δ 7.93 (d, J = 15.2 Hz, 1H), 7.53 (dd, J = 7.3, 1.7 Hz, 1H), 7.29 – 7.14 
(m, 3H), 6.70 (d, J = 15.2 Hz, 1H), 4.65 (d, J = 90.7 Hz, 2H), 3.50 – 3.38 (m, 6H), 
1.94 – 1.77 (m, 3H), 1.24 – 1.16 (m, 6H), 0.88 (d, J = 6.3 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ 
165.72 (C), 147.33 (C), 140.27 (CH), 139.02 (C), 135.27 (C), 130.91 (CH), 129.17 (CH), 126.62 
(CH), 126.53 (CH), 119.59 (CH), 113.13 (CH2), 46.24 (CH2), 42.33 (CH2), 41.07 (CH2), 39.71 (CH2), 
26.15 (CH), 22.58 (CH3), 15.16 (CH3), 13.33 (CH3). HRMS (ESI-TOF): m/z calculated for C20H30NO 
([M+H]+) 300.2322, found 300.2322.
(E)-3-(2-(2-(Cyclohexylmethyl)allyl)phenyl)-N,N-diethylacrylamide (1n)
This compound was prepared according the general procedure B starting 
from 2-cyclohexyl-N-methoxy-N-methylacetamide instead of N-methoxy-N,3-
dimethylbutanamide. 1H NMR (300 MHz, CDCl3):  δ 7.93 (d, J = 15.2 Hz, 
1H), 7.53 – 7.48 (m, 1H), 7.28 – 7.11 (m, 3H), 6.68 (d, J = 15.2 Hz, 1H), 4.64 
(d, J = 79.4 Hz, 2H), 3.48 – 3.37 (m, 6H), 1.90 (d, J = 7.1 Hz, 2H), 1.74 –
1.58 (m, 6H), 1.53 – 1.38 (m, 1H), 1.27 – 1.12 (m, 8H), 0.89 – 0.77 (m, 2H).
13C NMR (75 MHz, CDCl3): δ 165.57 (C), 146.63 (C), 140.16 (CH), 138.92 (C), 135.16 (C), 130.75 
(CH), 129.02 (CH), 126.50 (CH), 126.44 (CH), 119.49 (CH), 113.01 (CH2), 44.52 (CH2), 42.21 
(CH2), 40.96 (CH2), 39.74 (CH2), 35.50 (CH), 33.28 (CH2), 26.59 (CH2), 26.28 (CH2), 15.05 (CH3), 
13.22 (CH3). HRMS (ESI-TOF): m/z calculated for C23H34NO ([M+H]+) 340.2635, found 340.2635.
(E)-N,N-Diethyl-3-(2-(2-methylenehexyl)phenyl)acrylamide (1l)
This compound was prepared according the general procedure B starting from 
N-methoxy-N-methylpentanamide instead of N-methoxy-N,3-
dimethylbutanamide. 1H NMR (300 MHz, CDCl3):  δ 7.94 (d, J = 15.2 Hz, 1H), 
7.56 – 7.47 (m, 1H), 7.31 – 7.13 (m, 3H), 6.69 (d, J = 15.3 Hz, 1H), 4.82 (s, 1H), 
4.48 (s, 1H), 3.49 – 3.38 (m, 6H), 2.02 (t, J = 7.6 Hz, 2H), 1.50 – 1.38 (m, 2H), 
1.36 – 1.12 (m, 8H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 165.68 (C), 148.55 (C), 
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140.22 (CH), 138.95 (C), 135.17 (C), 130.82 (CH), 129.11 (CH), 126.56 (CH), 126.50 (CH), 119.49 
(CH), 111.42 (CH2), 42.28 (CH2), 41.02 (CH2), 39.95 (CH2), 35.99 (CH2), 29.90 (CH2), 22.46 (CH2), 
15.10 (CH3), 14.00 (CH3), 13.27 (CH3). HRMS (ESI-TOF): m/z calculated for C20H30NO ([M+H]+) 
300.2321, found 300.2322.
(E)-N,N-Diethyl-3-(2-(5-methyl-2-methylenehex-5-en-1-yl)phenyl)acrylamide (1t) 
This compound was prepared according the general procedure B starting from 
N-methoxy-N,4-dimethylpent-4-enamide instead of N-methoxy-N,3-
dimethylbutanamide. 1H NMR (300 MHz, CDCl3): δ 7.94 (d, J = 15.2 Hz, 1H), 
7.53 (dd, J = 7.5, 1.8 Hz, 1H), 7.32 – 7.12 (m, 3H), 6.70 (d, J = 15.4 Hz, 1H), 
4.85 (s, 1H), 4.70 – 4.65 (m, 2H), 4.52 (s, 1H), 3.53 – 3.38 (m, 6H), 2.20 – 2.14 
(m, 4H), 1.70 (s, 3H), 1.28 – 1.16 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 165.71 (C), 148.09 (C), 
145.52 (C), 140.23 (CH), 138.80 (C), 135.21 (C), 130.88 (CH), 129.20 (CH), 126.67 (CH), 126.56 
(CH), 119.57 (CH), 111.77 (CH2), 110.10 (CH2), 42.33 (CH2), 41.08 (CH2), 40.06 (CH2), 36.08 
(CH2), 34.42 (CH2), 22.53 (CH3), 15.15 (CH3), 13.31 (CH3). HRMS (ESI-TOF): m/z calculated for 
C21H30NO ([M+H]+) 312.2321, found 312.2322; m/z calculated for C21H29NNaO ([M+Na]+) 334.2142, 
found 334.2141.
General procedure C for preparation of precursors 1k and 1o (exemplified for the synthesis of 
1k)
1-Bromo-2-(2-methylallyl)benzene (S10)
This compound was synthetized according of a previous slightly modified 
procedure by Toste and coworkers.[6]
Prop-1-en-2-ylmagnesium bromide solution (0.5 M, 1 equiv) was slowly added to 
solution of 2-bromobenzyl bromide (2.50 g, 10.0 mmol), CuI (190.5 mg, 1.0 mmol,) and 2,2’-
bipyridyne (156.2 mg, 1.0 mmol) in toluene (15.1 mL) at 0 °C. The reaction was allowed to warm to 
rt and stirred for 4 h, when TLC indicates that the reaction is complete. NH4Cl (sat) (25 mL) was 
added. After extraction (3 × 25 mL, Et2O), the combined organic layers were dried and concentrated 




This compound was prepared according to the procedure described for the 
synthesis of S9 (see page S11). The product was isolated as clear oil (89% yield).
The NMR and MS analysis were consistent with those previously reported in the
literature.[6]
(E)-N,N-Diethyl-3-(2-(2-methylallyl)phenyl)acrylamide (1k)
Prepared following the previously shown Horner–Wadsworth–Emmons
procedure from S11 (see experimental procedure at page S7), the product was 
obtained in 76% yield as clear oil. 1H NMR (300 MHz, CDCl3):  δ 7.96 (d, J = 
15.2 Hz, 1H), 7.55 – 7.50 (m, 1H), 7.30 – 7.14 (m, 3H), 6.70 (d, J = 15.2 Hz, 
1H), 4.85 – 4.48 (m, 2H), 3.51 – 3.39 (m, 6H), 1.73 (s, 3H), 1.28 – 1.14 (m, 6H).
13C NMR (75 MHz, CDCl3): δ 165.78 (C), 144.46 (C), 140.23 (CH), 138.90 (C), 135.16 (C), 130.84 
(CH), 129.22 (CH), 126.68 (CH), 126.59 (CH), 119.53 (CH), 112.54 (CH2), 42.36 (CH2), 41.51 
(CH2), 41.11 (CH2), 22.87 (CH3), 15.17 (CH3), 13.33 (CH3). HRMS (ESI-TOF): m/z calculated for 
C17H24NO ([M+H]+) 258.1851, found 258.1852.
(E)-N,N-Diethyl-3-(2-(3-methylbut-3-en-1-yl)phenyl)acrylamide (1o)
This compound was prepared according the general procedure C using (2-
methylallyl)magnesium bromide instead of prop-1-en-2-ylmagnesium bromide.  
1H NMR (300 MHz, CDCl3): δ 8.01 (d, J = 15.2 Hz, 1H), 7.55 – 7.49 (m, 1H), 
7.27 – 7.15 (m, 3H), 6.73 (d, J = 15.2 Hz, 1H), 4.75 – 4.68 (m, 2H), 3.51 – 3.43 
(m, 4H), 2.92 – 2.86 (m, 2H), 2.30 – 2.23 (m, 2H), 1.77 (s, 3H), 1.29 – 1.16 (m, 
6H). 13C NMR (75 MHz, CDCl3): δ 165.71 (C), 145.03 (C), 141.55 (C), 139.89 (CH), 134.27 (C), 
129.81 (CH), 129.30 (CH), 126.51 (CH), 126.35 (CH), 119.59 (CH), 110.55 (CH2), 42.33 (CH2), 
41.10 (CH2), 39.40 (CH2), 31.75 (CH2), 22.68 (CH3), 15.15 (CH3), 13.31 (CH3). HRMS (ESI-TOF):
m/z calculated for C18H26NO ([M+H]+) 272.2009, found 272.2009.




Following a modified procedure reported by L. M. Stanley.[7] DMF (7.65 mL, 0.27 
M) was added to 1H-indole-2-carbaldehyde (300 mg, 2.06 mmol,) and Cs2CO3
(875 mg, 2.68 mmol) and the resulting mixture was stirred at rt for 0.5 h. 2-
(Bromomethyl)-4-methylpent-1-ene[8,9] (2.7 mmol) was added dropwise. The 
mixture was stirred at rt until the TLC indicates full conversion of the limiting 
reagent. Water (30 mL) was added to the mixture, and the resulting solution was extracted with 
EtOAc (3 x 10 mL). The combined organic layers were washed with water (100 mL), brine (100 mL), 
dried and concentrated to yield a crude residue that was purified by flash column chromatography 
on silica gel (hexane : EtOAc) to give the product as orange oil (404 mg, 81% yield). 1H NMR (300 
MHz, CDCl3): δ 9.88 (s, 1H), 7.78 – 7.73 (m, 1H), 7.44 – 7.32 (m, 2H), 7.29 (s, 1H), 7.22 – 7.15 (m, 
1H), 5.19 – 5.11 (m, 2H), 4.78 – 4.72 (m, 1H), 4.27 – 4.19 (m, 1H), 1.97 (d, J = 7.0 Hz, 2H), 1.93 –
1.83 (m, 1H), 0.95 (d, J = 6.3 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ 182.49 (CHO), 144.08, (C)
140.79 (C), 135.55 (C), 127.04 (CH), 126.45 (C), 123.43 (CH), 121.13 (CH), 117.96 (CH), 111.14 
(CH), 110.84 (CH2), 49.05 (CH2), 43.93 (CH2), 26.31 (CH), 22.62 (CH3). 
 
(E)-N,N-Diethyl-3-(1-(4-methyl-2-methylenepentyl)-1H-indol-2-yl)acrylamide (1r)
Prepared following the previously shown Horner–Wadsworth–Emmons
procedure from S12 (see experimental procedure at page S7) (471 mg, 
84% yield). 1H NMR (300 MHz, CDCl3): δ 7.79 (d, J = 15.1 Hz, 1H), 7.65 
(d, J = 7.9 Hz, 1H), 7.28 – 7.23 (m, 2H), 7.20 – 7.11 (m, 1H), 7.00 – 6.89 
(m, 2H), 4.86 (s, 1H), 4.73 (s, 2H), 4.43 (s, 1H), 3.57 – 3.45 (m, 4H), 2.00 
(d, J = 7.1 Hz, 2H), 1.96 – 1.85 (m, 1H), 1.32 – 1.20 (m, 6H), 1.00 (d, J = 6.3 Hz, 6H). 13C NMR (75 
MHz, CDCl3): δ 165.26 (C), 143.33 (C), 138.42 (C), 136.15 (C), 130.58 (CH), 127.52 (C), 122.99 
(CH), 120.93 (CH), 120.27 (CH), 118.32 (CH), 111.82 (CH2), 109.77 (CH), 102.20 (CH), 47.82 
(CH2), 43.59 (CH2), 42.20 (CH2), 41.08 (CH2), 26.34 (CH), 22.51 (CH3), 15.11 (CH3), 13.22 (CH3).
HRMS (ESI-TOF): m/z calculated for C22H31N2O ([M+H]+) 339.2432, found 339.2431.
(E)-N,N-Diethyl-3-(1-(2-methylenebutyl)-1H-indol-2-yl)acrylamide (1s)
This compound was prepared according the general procedure D using 2-
(bromomethyl)but-1-ene instead of 2-(bromomethyl)-4-methylpent-1-ene
(see the synthesis of S12 at page S14). 1H NMR (300 MHz, CDCl3): δ 7.80 
– 7.74 (m, 1H), 7.63 – 7.58 (m, 1H), 7.27 – 7.20 (m, 2H), 7.14 – 7.07 (m, 
1H), 6.96 – 6.84 (m, 2H), 4.86 (d, J = 1.2 Hz, 1H), 4.75 (s, 2H), 4.44 (d, J = 
1.0 Hz, 1H), 3.52 – 3.42 (m, 4H), 2.11 – 2.02 (m, 2H), 1.22 (dt, J = 16.7, 7.1 Hz, 6H), 1.12 (t, J = 7.4 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 165.39 (C), 146.21 (C), 138.56 (C), 136.23 (C), 130.73 (CH), 
127.58 (C), 123.07 (CH), 120.99 (CH), 120.34 (CH), 118.29 (CH), 109.92 (CH), 109.39 (CH2), 
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102.40 (CH), 48.19 (CH2), 42.29 (CH2), 41.19 (CH2), 26.39 (CH2), 15.18 (CH3), 13.28 (CH3), 11.97 
(CH3). HRMS (ESI-TOF): m/z calculated for C20H27N2O ([M+H]+) 311.2119, found 311.2118.
(E)-N,N-Diethyl-3-(2-(2-methylenebutoxy)phenyl)acrylamide (1p)
This compound was prepared according the general procedure D using 2-
hydroxybenzaldehyde and 2-(bromomethyl)but-1-ene as starting materials. 1H 
NMR (300 MHz, CDCl3): δ 7.94 (d, J = 15.5 Hz, 1H), 7.48 (dd, J = 7.6, 1.8 Hz, 
1H), 7.31 – 7.23 (m, 1H), 7.05 – 6.87 (m, 3H), 5.16 – 4.97 (m, 2H), 4.53 (s, 2H), 
3.51 – 3.41 (m, 4H), 2.19 (q, J = 7.5 Hz, 2H), 1.25 – 1.15 (m, 6H), 1.10 (t, J = 7.5 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.46 (C), 157.57 (C), 146.22 (C), 138.18 
(CH), 130.42 (CH), 129.79 (CH), 124.81 (C), 120.80 (CH), 119.12 (CH), 112.41 
(CH), 111.61 (CH2), 71.42 (CH2), 42.34 (CH2), 41.12 (CH2), 26.11 (CH2), 15.16 (CH3), 13.38 (CH3), 
12.10 (CH3). HRMS (ESI-TOF): m/z calculated for C18H26NO2 ([M+H]+) 288.1958, found 288.1958.
(E)-N,N-Diethyl-3-(2-((4-methyl-2-methylenepentyl)oxy)phenyl) acrylamide (1q)
This compound was prepared according the general procedure D using 2-
hydroxybenzaldehyde and 2-(bromomethyl)-4-methylpent-1-ene as starting 
materials. 1H NMR (300 MHz, CDCl3): δ 7.91 (d, J = 15.5 Hz, 1H), 7.44 (dd, J = 
7.6, 1.7 Hz, 1H), 7.27 – 7.17 (m, 1H), 7.05 – 6.80 (m, 3H), 5.06 (dd, J = 64.4, 
1.5 Hz, 2H), 4.46 (s, 2H), 3.48 – 3.38 (m, 4H), 2.03 – 2.00 (m, 2H), 1.83 – 1.71 
(m, 1H), 1.25 – 1.11 (m, 6H), 0.88 (d, J = 6.5 Hz, 6H). 13C NMR (75 MHz, 
CDCl3): δ 166.32 (C), 157.45 (C), 143.34 (C), 138.02 (CH), 130.30 (CH), 129.63 
(CH), 124.78 (C), 120.72 (CH), 119.13 (CH), 113.71 (CH2), 112.38 (CH), 70.90 (CH2), 43.05 (CH2), 
42.23 (CH2), 40.97 (CH2), 26.23 (CH3), 22.50 (CH3), 15.06 (CH3), 13.26 (CH3). HRMS (ESI-TOF):
m/z calculated for C20H30NO2 ([M+H]+) 316.2272, found 316.2271.
Procedure E for preparation of precursors 5a and 5b (exemplified for the synthesis of 5b)
N,N-Diethyl-3-hydroxybenzamide (S13)
3-Hydroxybenzoic acid (5.0 g, 36.2 mmol) was placed in a flask equipped with a 
reflux condenser. Thionyl chloride (20 mL, 270 mmol) and a few drops of DMF 
were added and the mixture was refluxed for 4 hours. The reaction was allowed to 
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cool to rt and the excess of SOCl2 was carefully removed with a rotary evaporator equipped with a 
intermediate cooled trap (Et2O – N2 bath). The crude acid chloride was dissolved in CH2Cl2 (72 mL) 
and Et3N (15.26 mL, 108.6 mmol) was added. The mixture was cooled in a ice-water bath and 
Et2NH (13.9 mL, 133.9 mmol) was added dropwise. The reaction was stirred for 19 hours at rt, 
concentrated and the resulting crude mixture was purified via flash column chromatography (1:2 to 
3:1 EtOAc: Hex) to provide the amide product as yellow solid (6.50 g, 95% yield). The NMR and MS 
analysis were consistent with those previously published.[10]
N,N-Diethyl-3-(2-methylenebutoxy)benzamide (5b)
2-(Bromomethyl)but-1-ene (463 mg, 3.1 mmol) was added dropwise to a solution of 
N,N-diethyl-3-hydroxybenzamide (S13, 500 mg, 2.59 mmol) and K2CO3 (430 mg, 
3.1 mmol) in DMF (3 mL). The mixture was stirred 20 hours at rt, diluted with Et2O 
(10 mL) and washed with water (3 x 15 mL). The organic phase was dried, 
concentrated and chromatographed to yield 5b as colorless oil (278 mg, 41 %). 1H 
NMR (300 MHz, CDCl3): δ 7.28 – 7.21 (m, 1H), 6.93 – 6.86 (m, 3H), 5.02 (d, J = 37.6 Hz, 2H), 4.45 
(s, 2H), 3.58 – 3.11 (m, 4H), 2.12 (q, J = 7.4 Hz, 2H), 1.25 – 1.01 (m, 9H). 13C NMR (75 MHz, 
CDCl3):  δ 170.98 (C), 158.80 (C), 146.20 (C), 138.56 (C), 129.52 (CH), 118.53 (CH), 115.76 (CH), 
112.61 (CH), 110.98 (CH2), 71.03 (CH2), 43.22 (CH2), 39.15 (CH2), 25.85 (CH2), 14.20 (CH3), 12.90 
(CH3), 12.02 (CH3). HRMS (ESI-TOF): m/z calculated for C16H24NO2 ([M+H]+) 262.1801, found 
262.1802.
N,N-Diethyl-3-((2-methylallyl)oxy)benzamide (5a)
This compound was prepared according the general procedure E using 3-bromo-
2-methylprop-1-ene as alkylating agent. 1H NMR (300 MHz, CDCl3): δ 7.29 – 7.22 
(m, 1H), 6.94 – 6.87 (m, 3H), 5.08 – 4.94 (m, 2H), 4.41 (s, 2H), 3.58 – 3.14 (m, 4H), 
1.80 (s, 3H), 1.27 – 1.00 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 170.99 (C), 158.77 
(C), 140.65 (C), 138.58 (C), 129.55 (CH), 118.60 (CH), 115.78 (CH), 112.86 (CH2), 
112.66 (CH), 71.83 (CH2), 43.29 (CH2), 39.26 (CH2), 19.43 (CH3), 14.30 (CH3), 12.98 (CH3). HRMS 
(ESI-TOF): m/z calculated for C15H22NO2 ([M+H]+) 248.1645, found 248.1645.
Synthesis of N,N-Diethyl-1-(3-methylbut-3-en-1-yl)-1H-pyrrole-3-carboxamide (5c).
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N,N-Diethyl-1H-pyrrole-3-carboxamide (S14)
Et2NH (2.14 mL, 20.7 mmol) was added to a solution of 1H-pyrrole-3-carboxylic acid 
(2.0 g, 18.0 mmol), EDC.HCl (5.17 g, 27.0 mmol) and Et3N (7.5 mL, 53.9 mmol) in 
CH2Cl2 (72 mL, 0.25 M). The resulting mixture was stirred for 16 h and then water (50 
mL) was added. The layers were separated and the aqueous phase was extracted 
with CH2Cl2 (2 x 50 mL). The combined organic layers were dried and concentrated to yield a crude
residue that was purified by column chromatography (1:1 to 9:1, EtOAc : Hexane) to yield S14 as a
pale yellow solid (1.88 g, 63% yield). 1H NMR (300 MHz, CDCl3): δ 10.40 (s, 1H), 6.97 – 6.92 (m, 
1H), 6.61 – 6.57 (m, 1H), 6.34 – 6.30 (m, 1H), 3.52 (q, J = 7.1 Hz, 4H), 1.20 (t, J = 7.1 Hz, 6H). 13C 
NMR (75 MHz, CDCl3): δ 167.87 (C), 121.01 (CH), 118.98 (C), 118.22 (CH), 108.31 (CH), 41.75 
(CH2), 13.82 (CH3). HRMS (ESI): m/z calculated for C9H15N2O ([M+H]+) 167.1178, found 167.1179.
N,N-Diethyl-1-(3-methylbut-3-en-1-yl)-1H-pyrrole-3-carboxamide (5c)
Prepared following a modified procedure from Schreiber and coworkers.[11] 3-
methylbut-3-en-1-yl 4-methylbenzenesulfonate (694 mg, 2.9 mmol) was slowly 
added to a solution of N,N-diethyl-1H-pyrrole-3-carboxamide (300 mg, 1.80 mmol) 
and cesium carbonate (1.35 g, 4.14 mmol) in anhydrous DMF (4.5 mL, 0.4 M). The 
reaction mixture was stirred at 85 ºC for 16 hours, allowed to cool to rt and water (30 mL) was 
added. The mixture was extracted with Et2O (5 x 10 mL). The organic phase was dried, 
concentrated and the crude residue was purified by flash chromatography (1:3 to 2:1 AcOEt : 
Hexane) to yield 5c as clear oil (402 mg, 96% yield). 1H NMR (500 MHz, CDCl3): δ 7.04 – 7.01 (m, 
1H), 6.56 – 6.52 (m, 1H), 6.29 – 6.26 (m, 1H), 4.78 – 4.76 (m, 1H), 4.66 (s, 1H), 3.94 (t, J = 7.4 Hz, 
2H), 3.49 (q, J = 7.1 Hz, 4H), 2.44 (t, J = 7.4 Hz, 2H), 1.71 (s, 3H), 1.18 (td, J = 7.1, 1.5 Hz, 6H). 13C 
NMR (126 MHz, CDCl3): δ 166.58 (C), 141.77 (C), 123.59 (CH), 120.36 (CH), 119.32 (C), 112.66 
(CH2), 108.78 (CH), 48.41 (CH2), 41.43 (CH2), 39.45 (CH2), 22.41 (CH3), 13.79 (CH3). HRMS (ESI-
TOF): m/z calculated for C14H23N2O ([M+H]+) 235.1806, found 235.1805.
Synthesis of N,N-Diethyl-1-(3-methylbut-3-en-1-yl)-1H-indole-3-carboxamide (5d).
1-(3-Methylbut-3-en-1-yl)-1H-indole (S15)
Following a modified reported procedure.[12] Indole (1.17 g, 10.0 mmol, 1.0 
equiv) was added in portions to a NaH (560 mg, 14.0 mmol, 1.4 equiv) 
suspension in DMF (25 mL, 0.4 M), at 0ºC. The reaction mixture was then
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warmed to 50 °C to ensure complete deprotonation. Subsequently, it was cooled to 0 °C and 3-
methyl-3-butenyl methanesulfonate[13] was added dropwise. (CAUTION, the reaction is very 
exothermic!) The ice bath was removed and the reaction mixture was allowed to slowly warm up 
and stirred overnight at rt. After quenching with water, the aqueous phase was extracted with 
hexane (4 x 20 mL), the combined organic layers were washed with brine, dried, filtered and the 
organic phases were concentrated to yield a crude residue that was purified by flash 
chromatography (hexane–EtOAc = 99:1) to afford the product as a colorless oil (690 mg, 37%
yield). The data was consistent with that previously described.[12]
1-(3-Methylbut-3-en-1-yl)-1H-indole-3-carboxylic acid (S16)
To a solution of 1-(3-Methylbut-3-en-1-yl)-1H-indole (S15, 690 mg, 3.72 mmol, 1 
equiv) in CH2Cl2 (5.0 mL, 0.75 M) at 0 ºC was added dropwise trifluoroacetic 
anhydride (0.79 mL, 5.59 mmol). The solution was stirred at rt for 1h, and the
volatile components were removed in a rotary evaporator under vacuum: The
crude product was carried to the next step without further purification. To a solution of 2,2,2-
Trifluoro-1-(1-(3-methylbut-3-en-1-yl)-1H-indol-3-yl)ethan-1-one (1.04 g, 3.72 mmol) in MeOH (3.7 
mL, 1 M), was added an aqueous solution of KOH (3.7 mL, 5M). The mixture was stirred overnight 
at 80 ºC. The reaction was cooled to rt and HCl (10 %) was added until the solution reach pH 1-2. 
At this point, the mixture was extracted with EtOAc (3 x 10 mL). The organic layer was dried with 
Na2SO4 and the solvent was removed. The pure product (825 mg, 97% yield) was obtained as 
white solid after column chromatography (1:3 to 2:1, EtOAc:Hexane). The data was consistent with 
the previous described.[14]
N,N-Diethyl-1-(3-methylbut-3-en-1-yl)-1H-indole-3-carboxamide (5d)
To a solution of 1-(3-Methylbut-3-en-1-yl)-1H-indole-3-carboxylic acid (S16, 
825 mg,  3.60 mmol, 1.0 equiv), in CH2Cl2 (58 mL, 0.06 M) and DMF (2.9 mL, 
1.25M), EDC.HCl (897 mg, 4.68 mmol, 1.3 equiv), HOBt (606 mg, 3.96 mmol, 
1.1 equiv) and triethylamine (1.6 mL, 11.52 mmol, 3.2 equiv) were added. The 
mixture was stirred 20 minutes and diethylamine (0.43 mL, 4.14 mmol, 1.15 equiv) was added. The 
resulting mixture was stirred at 40 ºC for 4 h and at rt for 16 hours. The reaction was poured into 
water and the organic layer was separated. The aqueous phase was extracted with EtOAc (3 x 20 
mL) The combined organic layers were washed and dried with Na2SO4 and the solvent was 
evaporated. The crude product was purified by column chromatography (1:2 to 3:1, AcOEt:Hexane). 
The indole derivative was obtained as beige solid (645 mg, 63 %). 1H NMR (300 MHz, CDCl3): δ 
7.74 (d, J = 7.8 Hz, 1H), 7.32 – 7.27 (m, 2H), 7.23 – 7.10 (m, 2H), 4.77 – 4.61 (m, 2H), 4.17 (t, J = 
7.3 Hz, 2H), 3.55 – 3.47 (m, 4H), 2.48 (t, J = 7.4 Hz, 2H), 1.72 (s, 3H), 1.20 – 1.13 (m, 6H). 13C 
NMR (75 MHz, CDCl3): δ 166.81 (C), 141.84 (C), 135.56 (C), 128.26 (CH), 126.98 (C), 122.29 (CH), 
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121.08 (CH), 120.60 (CH), 112.91 (CH2), 111.14 (C), 109.52 (CH), 45.08 (CH2), 41.34 (CH2), 37.98 
(CH2), 22.47 (CH3), 13.96 (CH3). HRMS (ESI-TOF): m/z calculated for C18H25N2O ([M+H]+) 
285.1961, found 285.1961.
Synthesis of ketones, ester and acid 1c, 1u, 1v, and 1w. 
(E)-8-Methylenedodec-3-en-2-one (1c)
5-Methylenenonanal (700 mg, 4.54 mmol) was added to a solution of 1-(triphenyl-5-
phosphaneylidene)propan-2-one (1.7 g, 5.45 mmol, 1.2 equiv) in CHCl3 (18 mL, 0.25 M) The 
mixture was stirred for 20 hours at rt, the solvent was removed, and the crude residue was purified 
by column chromatography (1:10, Et2O:Hexane) to afford (E)-8-methylenedodec-3-en-2-one as 
clear oil (514 mg, 58% yield). 1H NMR (300 MHz, CDCl3): δ 6.79 (dt, J = 16.0, 6.9 Hz, 1H), 6.06 (dt, 
J = 15.9, 1.5 Hz, 1H), 4.73 – 4.67 (m, 2H), 2.26 – 2.16 (m, 5H), 2.00 (dt, J = 13.9, 7.8 Hz, 4H), 1.65 
– 1.53 (m, 2H), 1.44 – 1.23 (m, 4H), 0.88 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 198.69 
(C), 149.16 (C), 148.25 (CH), 131.53 (CH), 109.32 (CH2), 35.73 (CH2), 35.50 (CH2), 32.13 (CH2), 
30.06 (CH2), 26.93 (CH3), 26.19 (CH2), 22.55 (CH2), 14.07 (CH3). MS (ESI): ([M+H]+) 195.2
(E)-7-Methylene-1-phenylundec-2-en-1-one (1w) 
Prepared following the procedure for the synthesis of 1c, using 1-phenyl-2-(triphenyl-
5-phosphaneylidene)ethan-1-one as Wittig reagent. 1H NMR (300 MHz, CDCl3): δ
7.90 (d, J = 7.4 Hz, 2H), 7.53 – 7.45 (m, 1H), 7.40 (t, J = 7.4 Hz, 2H), 7.10 – 6.98 (m, 
1H), 6.86 (d, J = 15.4 Hz, 1H), 4.71 (d, J = 6.6 Hz, 2H), 2.33 – 2.22 (m, 2H), 2.07 –
1.94 (m, 4H), 1.70 – 1.56 (m, 2H), 1.44 – 1.23 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H). 13C 
NMR (75 MHz, CDCl3): δ 190.47 (C), 149.44 (CH), 148.95 (C), 137.90 (C), 132.48 (CH), 128.41 
(CH), 125.95 (CH), 109.21 (CH2), 35.58 (CH2), 35.41 (CH2), 32.32 (CH2), 29.91 (CH2), 26.15 (CH2), 
22.41 (CH2), 13.94 (CH3). MS (ESI): ([M+H]+) 257.2
Ethyl (E)-7-methyleneundec-2-enoate (1u)
Prepared following the procedure for the synthesis of 1c, using ethyl 2-(triphenyl-5-
phosphaneylidene)acetate as Wittig reagent.1H NMR (300 MHz, CDCl3): δ 6.95 (dt, 
J = 15.5, 6.9 Hz, 1H), 5.81 (d, J = 15.7 Hz, 1H), 4.70 (d, J = 8.2 Hz, 2H), 4.17 (q, J = 
7.1 Hz, 2H), 2.23 – 2.14 (m, 2H), 2.05 – 1.94 (m, 4H), 1.64 – 1.52 (m, 2H), 1.44 –
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1.21 (m, 7H), 0.89 (t, J = 7.0 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.81 (C), 149.27 (C), 149.15 
(CH), 121.59 (CH), 109.27 (CH), 60.24 (CH2), 35.76 (CH2), 35.50 (CH2), 31.88 (CH2), 30.09 (CH2), 
26.16 (CH2), 22.58 (CH2), 14.38 (CH3), 14.09 (CH3). HRMS (ESI-TOF): m/z calculated for 
C14H24NaO2 ([M+Na]+) 247.1662, found 247.1669.
(E)-7-Methyleneundec-2-enoic acid (1v). 
LiOH (42 mg, 0.178 mmol, 2 equiv) in water (3.3 mL) was added to a solution of ethyl 
(E)-7-methyleneundec-2-enoate (1u, 200 mg, 0.89 mmol, 1 equiv) in MeOH (1.6 mL) 
and THF (4 mL), and the reaction mixture was stirred at 45 ºC for 20 hours. Then, HCl 
(10 %) was added until a pH of 1-2 was reached. After extraction with EtOAc (3 x 10 
mL), the organic layer was dried and the solvent removed. The pure product (156 mg, 
89% yield) was obtained as white solid after column chromatography (1:3 to 1:1, AcOEt:Hexane).
1H NMR (300 MHz, CDCl3): δ 11.60 (s, 1H), 7.09 (dt, J = 15.6, 7.0 Hz, 1H), 5.84 (dt, J = 15.6, 1.6 
Hz, 1H), 4.76 – 4.68 (m, 2H), 2.29 – 2.18 (m, 2H), 2.08 – 1.96 (m, 4H), 1.68 – 1.55 (m, 2H), 1.45 –
1.25 (m, 4H), 0.90 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 172.41 (C), 152.25 (CH), 149.18 
(C), 121.02 (CH), 109.41 (CH2), 35.77 (CH2), 35.51 (CH2), 32.01 (CH2), 30.11 (CH2), 26.02 (CH2), 
22.61 (CH2), 14.12 (CH3). MS (ESI): ([M+H]+) 197.1
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Procedure for the Iridium-catalyzed intramolecular hydrocarbonation reaction
or 
 
Ir(cod)2BArF (0.05 equiv), dFppe (0.05 equiv), the carboxamide precursor (typically 50 -200 mg, 1.0 
equiv) and the appropriate solvent [dioxane or 1,2-DCE (0.124 M)] were sequentially added to a 
Schlenk tube under Argon. The reaction mixture was then stirred at the appropriate temperature
[100 °C for dioxane or 140 ºC for 1,2-DCE (in a sealed tube)]. After 19 h, the reaction mixture was 
concentrated and the crude residue was purified by flash chromatography on silica gel (typically
1:20 to 1:10 EtOAc : Hexanes) to afford the cyclic product.
(Z)-2-(2-Butyl-2-methylcyclopentylidene)-N,N-diethylacetamide (2a)
Carried out in refluxing dioxane. The product was isolated by flash chromatography (5 
to 10 % EtOAc/Hexanes) as a pale yellow oil (91% yield). 1H NMR (300 MHz, CDCl3):  
δ 5.82 (t, J = 2.1 Hz, 1H), 3.51 – 3.20 (m, 4H), 2.48 – 2.38 (m, 2H), 1.77 – 1.38 (m, 
8H), 1.28 – 1.22 (m, 2H), 1.20 (s, 3H), 1.15 – 1.08 (m, 6H), 0.85 (t, J = 7.0 Hz, 3H).
13C NMR (75 MHz, CDCl3): δ 167.81 (C), 161.80 (C), 114.45 (CH), 46.18 (C), 42.57 (CH2), 40.70 
(CH2), 39.15 (CH2), 38.51 (CH2), 36.88 (CH2), 27.37 (CH2), 25.44 (CH3), 23.60 (CH2), 22.68 (CH2), 
14.34 (CH3), 13.99 (CH3), 12.90 (CH3). HRMS (ESI-TOF): m/z calculated for C16H30NO ([M+H]+) 
252.2322, found 252.2322. 
(Z)-2-(2-Butyl-2-methylcyclopentylidene)-1-(pyrrolidin-1-yl)ethan-1-one (2b)
Carried out in refluxing dioxane. The product was isolated by flash chromatography (5 
to 15 % EtOAc/Hexanes) as a yellow pale oil (44 %). 1H NMR (400 MHz, CDCl3): δ 
5.84 (s, 1H), 3.50 – 3.34 (m, 4H), 2.51 – 2.36 (m, 2H), 1.95 – 1.81 (m, 4H), 1.78 – 1.71 
(m, 2H), 1.71 – 1.57 (m, 4H), 1.49 – 1.42 (m, 1H), 1.27 – 1.24 (m, 5H), 1.14 – 1.04 (m, 
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1H), 0.86 (t, J = 6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 166.55 (C), 163.63 (C), 114.80 (CH), 
46.20 (C), 40.93 (CH2), 38.19 (CH2), 37.74 (CH2), 27.39 (CH2), 25.59 (CH3), 23.61 (CH2), 22.86 
(CH2), 14.36 (CH3). HRMS (ESI-TOF): m/z calculated for C16H28NO ([M+H]+) 250.2167, found 
250.2165.
(Z)-2-(2,2-Dimethylcyclopentylidene)-N,N-diethylacetamide (2d)
Carried out in refluxing dioxane. The product was isolated by flash chromatography (5 
to 10 % EtOAc/Hexanes) as a pale yellow oil (80% yield). 1H NMR (500 MHz, CDCl3): 
δ 5.81 (t, J = 2.1 Hz, 1H), 3.38 (q, J = 7.1 Hz, 2H), 3.32 (q, J = 7.1 Hz, 2H), 2.47 (td, J
= 7.3, 2.1 Hz, 2H), 1.67 – 1.59 (m, 2H), 1.56 (t, J = 6.4 Hz, 2H), 1.22 (s, 5H), 1.14 –
1.10 (m, 7H). 13C NMR (126 MHz, CDCl3): δ 167.99 (C), 161.21 (C), 114.67 (CH), 44.76 (CH2), 
42.86 (C), 42.69 (CH2), 39.18 (CH2), 36.05 (CH2), 26.88 (CH3), 22.44 (CH2), 14.06 (CH3), 12.90 
(CH3). HRMS (ESI-TOF): m/z calculated for C13H24NO ([M+H]+) 210.1851, found 210.1852.
(Z)-N,N-Diethyl-2-(2-isobutyl-2-methylcyclopentylidene)acetamide (2e)
Carried out in refluxing dioxane. The product was isolated by flash chromatography (5 
to 10 % EtOAc/Hexanes) as a pale yellow oil (93% yield). 1H NMR (300 MHz, CDCl3): 
δ 5.81 – 5.78 (m, 1H), 3.52 – 3.38 (m, 1H), 3.37 – 3.21 (m, 3H), 2.48 – 2.41 (m, 2H), 
1.80 – 1.72 (m, 1H), 1.70 – 1.57 (m, 4H), 1.54 – 1.40 (m, 2H), 1.23 (s, 3H), 1.15 –
1.08 (m, 6H), 0.93 – 0.83 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 167.99 (C), 162.65 (C), 114.37 
(CH), 47.05 (CH2), 46.52 (C), 42.54 (CH2), 41.06 (CH2), 39.10 (CH2), 36.51 (CH2), 25.51 (CH), 
25.34 (CH3), 25.24 (CH3), 24.85 (CH3), 22.52 (CH2), 13.87 (CH3), 12.77 (CH3). HRMS (ESI-TOF):
m/z calculated for C16H30NO ([M+H]+) 252.2322, found 252.2322. 
(Z)-N,N-Diethyl-2-(2-isopropyl-2-methylcyclopentylidene)acetamide (2f)
Carried out in refluxing dioxane. The product was isolated by flash chromatography (5 
to 10 % EtOAc/Hexanes) as a yellow oil (96% yield). 1H NMR (300 MHz, CDCl3):  δ 
5.88 – 5.85 (m, 1H), 3.47 – 3.23 (m, 4H), 2.53 – 2.25 (m, 3H), 1.82 – 1.70 (m, 1H), 
1.67 – 1.50 (m, 2H), 1.36 – 1.27 (m, 1H), 1.24 (s, 3H), 1.17 – 1.07 (m, 6H), 0.86 –
0.75 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 167.72 (C), 162.70 (C), 114.01 (CH), 49.76 (C), 42.38 
(CH2), 39.04 (CH2), 38.70 (CH2), 35.01 (CH2), 33.13 (CH), 25.43 (CH3), 22.90 (CH2), 18.54 (CH3), 
17.89 (CH3), 13.92 (CH3), 12.74 (CH3). HRMS (ESI-TOF): m/z calculated for C15H28NO ([M+H]+) 
238.2161, found 238.2165. 
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(Z)-2-(2-Benzyl-2-methylcyclopentylidene)-N,N-diethylacetamide (2g)
Carried out in refluxing Dioxane. The product was isolated by flash chromatography (5 
to 10 % EtOAc/Hexanes) as yellow oil (94% yield). 1H NMR (300 MHz, CDCl3): δ 7.20 
– 7.10 (m, 5H), 5.87 (t, J = 1.6 Hz, 1H), 3.40 – 3.28 (m, 3H), 3.02 – 2.88 (m, 2H), 2.43 
– 2.25 (m, 2H), 1.82 – 1.68 (m, 1H), 1.53 – 1.42 (m, 2H), 1.28 – 1.19 (m, 2H), 1.15 (s, 
3H), 1.14 - 1.06 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 167.92 (C), 162.01 (C), 139.98 (C), 130.92 
(CH), 127.84 (CH), 125.94 (CH), 115.07 (CH), 47.06 (C), 44.31 (CH2), 42.64 (CH2), 40.08 (CH2), 
39.35 (CH2), 36.76 (CH2), 24.79 (CH3), 22.28 (CH2), 14.01 (CH3), 12.88 (CH3). HRMS (ESI-TOF):
m/z calculated for C19H28NO ([M+H]+) 286.2164, found 286.2165. 
(Z)-N,N-Diethyl-2-(2-methyl-2-phenylcyclopentylidene)acetamide (2h)
Carried out in 1,2-DCE at 140 ºC (in a sealed tube). The product was isolated by flash 
chromatography (5 to 15 % EtOAc/Hexanes) as white solid (83% yield). 1H NMR (400 
MHz, CDCl3 ): δ 7.33 – 7.28 (m, 2H), 7.22 (t, J = 7.7 Hz, 2H), 7.11 – 7.06 (m, 1H), 
5.92 (t, J = 2.1 Hz, 1H), 3.22 – 3.13 (m, 2H), 2.86 – 2.74 (m, 2H), 2.72 – 2.65 (m, 2H), 
2.09 – 2.01 (m, 1H), 1.89 – 1.73 (m, 3H), 1.71 (s, 3H), 1.02 (t, J = 7.2 Hz, 3H), 0.63 (t, J = 7.2 Hz, 
3H). 13C NMR (101 MHz, CDCl3): δ 166.66 (C), 161.78 (C), 148.08 (C), 127.65 (CH), 126.93 (CH), 
125.44 (CH), 116.16 (CH), 50.86 (C), 47.71 (CH2), 42.10 (CH2), 38.83 (CH2), 36.08 (CH2), 24.73 
(CH3), 23.08 (CH2), 13.89 (CH3), 12.59 (CH3). HRMS (ESI-TOF): m/z calculated for C18H26NO 
([M+H]+) 272.2005, found 272.2009.
(Z)-N,N-Diethyl-2-(2-methylcyclopentylidene)acetamide (2i)
Carried out in 1,2-DCE at 140 ºC (in a sealed tube). The product was isolated by flash 
chromatography (2 to 10 % EtOAc/Hexanes) as a yellow pale oil (38% yield). 1H NMR 
(400 MHz, CDCl3): δ 5.96 – 5.94 (m, 1H), 3.51 – 3.28 (m, 5H), 2.56 – 2.43 (m, 1H), 
2.41 – 2.29 (m, 1H), 1.92 – 1.82 (m, 1H), 1.77 – 1.65 (m, 1H), 1.64 – 1.53 (m, 1H), 
1.47 – 1.38 (m, 1H), 1.18 – 1.11 (m, 6H), 1.06 (d, J = 7.0 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 
167.18 (C), 165.21 (C), 112.54 (CH), 42.41 (CH2), 39.93 (CH2), 36.53 (CH), 35.17 (CH2), 34.98 
(CH2), 23.29 (CH2), 19.98 (CH3), 14.59 (CH3), 13.28 (CH3). HRMS (ESI-TOF): m/z calculated for 
C12H22NO ([M+H]+) 196.1697, found 196.1696.
(Z)-2-(2-Butyl-2-methylcyclopentylidene)-N,N-diethylpropanamide (2j)
98% yield. {NOTE: The presence of two rotamers is clearly observed in the 1H and 
13C NMR spectra. This was further confirmed by performing the spectra at different 
temperatures} 1H NMR (300 MHz, CDCl3, rt): δ 3.71 – 3.53 (m, 1H), 3.49 – 3.36 (m, 
1H), 3.23 – 3.05 (m, 2H), 2.38 – 2.17 (m, 2H), 1.71 (s, 3H), 1.66 – 1.44 (m, 5H), 1.32
– 1.07 (m, 14H), 0.84 (t, J = 7.0 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 172.80 (C), 172.68 (C), 
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149.69 (C), 148.77 (C), 121.98 (C), 121.91 (C), 46.11 (C), 46.07 (C), 42.61 (CH2), 42.40 (CH2), 
40.73 (CH2), 39.80 (CH2), 38.90 (CH2), 38.71 (CH2), 37.44 (CH2), 37.28 (CH2), 32.30 (CH2), 32.12 
(CH2), 27.48 (CH2), 27.08 (CH2), 24.64 (CH3), 23.78 (CH2), 23.59 (CH3), 23.48 (CH2), 21.93 (CH2), 
21.73 (CH2)*, 19.04 (CH3), 19.01 (CH3), 14.36 (CH3), 14.33 (CH3), 13.91 (CH3), 13.81 (CH3), 12.29 
(CH3). HRMS (ESI-TOF): m/z calculated for C17H32NO ([M+H]+) 266.2479, found 266.2478.
(E)-2-(2,2-Dimethyl-2,3-dihydro-1H-inden-1-ylidene)-N,N-diethylacetamide (2k)
Carried out in refluxing dioxane. The product was isolated by flash 
chromatography (5 to 10 % EtOAc/Hexanes) as a yellow solid (99% yield). 1H 
NMR (300 MHz, CDCl3):  δ 7.38 (d, J = 7.3 Hz, 1H), 7.23 – 7.09 (m, 3H), 6.32 
(s, 1H), 3.46 – 3.27 (m, 5H), 2.79 (s, 2H), 1.34 (s, 6H), 1.16 – 1.04 (m, 6H). 13C 
NMR (75 MHz, CDCl3): δ 167.72 (C), 158.03 (C), 144.54 (C), 140.50 (C), 129.39 (CH), 126.69 (CH), 
125.43 (CH), 121.15 (CH), 112.14 (CH), 49.06 (C), 44.28 (CH2), 42.80 (CH2), 39.35 (CH2), 27.31 
(CH3), 14.09 (CH3), 12.87 (CH3). HRMS (ESI-TOF): m/z calculated for C17H24NO ([M+H]+) 258.1852, 
found 258.1852.
(E)-2-(2-Butyl-2-methyl-2,3-dihydro-1H-inden-1-ylidene)-N,N-diethylacetamide (2l)
Carried out in refluxing dioxane. The product was isolated by flash 
chromatography (5 to 10 % EtOAc/Hexanes) as a pale yellow oil (99% yield). 
1H NMR (500 MHz, CDCl3): δ 7.47 (d, J = 7.6 Hz, 1H), 7.31 – 7.19 (m, 3H), 
6.46 (s, 1H), 3.53 – 3.36 (m, 4H), 3.05 (d, J = 16.5 Hz, 1H), 2.74 (d, J = 16.5 
Hz, 1H), 1.89 (ddd, J = 13.0, 11.9, 4.5 Hz, 1H), 1.75 (ddd, J = 13.1, 12.1, 4.4 Hz, 1H), 1.40 (s, 3H), 
1.31 – 1.23 (m, 3H), 1.20 (t, J = 7.1 Hz, 6H), 1.17 – 1.10 (m, 1H), 0.85 (t, J = 7.2 Hz, 3H). 13C NMR 
(75 MHz, CDCl3): δ 167.60 (C), 158.12 (C), 145.12 (C), 141.02 (C), 129.43 (CH), 126.65 (CH), 
125.33 (CH), 120.85 (CH), 112.07 (CH), 47.61 (C), 45.71 (CH2), 41.5 (br, CH2) 39.37 (CH2), 27.56 
(CH3), 26.46 (CH2), 23.51 (CH2), 14.25 (CH3), 13.52 (CH3). HRMS (ESI-TOF): m/z calculated for 
C20H30NO ([M+H]+) 300.2322, found 300.2322. 
(E)-N,N-Diethyl-2-(2-isobutyl-2-methyl-2,3-dihydro-1H-inden-1-ylidene)acetamide (2m)
Carried out in refluxing dioxane. The product was isolated by flash 
chromatography (5 to 10 % EtOAc/Hexanes) as a colorless oil (99% yield) 
1H NMR (300 MHz, CDCl3) δ 7.48 – 7.42 (m, 1H), 7.31 – 7.17 (m, 3H), 6.42 (s, 
1H), 3.51 – 3.34 (m, 4H), 3.10 (d, J = 16.6 Hz, 1H), 2.79 (d, J = 16.6 Hz, 1H), 
1.90 – 1.70 (m, 2H), 1.70 – 1.55 (m, 1H), 1.40 (s, 3H), 1.18 (t, J = 7.2 Hz, 6H), 0.86 (t, J = 6.5 Hz, 
6H). 13C NMR (75 MHz, CDCl3): δ 167.59 (C), 158.80 (C), 145.22 (C), 140.97 (C), 129.48 (CH), 
126.68 (CH), 125.32 (CH), 120.89 (CH), 111.98 (CH), 48.35 (CH2), 47.75 (C), 46.49 (CH2), 41.0 (br, 
CH2) 26.87 (CH3), 25.70 (CH), 25.04 (CH3), 24.69 (CH3), 13.48 (CH3). HRMS (ESI-TOF): m/z 
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calculated for C20H30NO ([M+H]+) 300.2322, found 300.2322; m/z calculated for C20H29NONa 
([M+Na]+) 322.2143, found 322.2141.
(E)-2-(2-(Cyclohexylmethyl)-2-methyl-2,3-dihydro-1H-inden-1-ylidene)-N,N-diethylacetamide 
(2n)
Carried out in refluxing dioxane. The product was isolated by flash 
chromatography (5 to 10 % EtOAc/Hexanes) as a colorless oil (98% yield). 1H 
NMR (500 MHz, CDCl3): δ 7.47 – 7.44 (m, 1H), 7.29 – 7.25 (m, 1H), 7.24 –
7.19 (m, 2H), 6.41 (s, 1H), 3.51 – 3.33 (m, 4H), 3.09 (d, J = 16.5 Hz, 1H), 2.78 
(d, J = 16.5 Hz, 1H), 1.80 – 1.71 (m, 2H), 1.69 – 1.51 (m, 5H), 1.40 (s, 3H), 1.33 – 1.25 (m, 1H), 
1.19 (t, J = 7.1 Hz, 6H), 1.16 – 1.05 (m, 3H), 1.02 – 0.89 (m, 2H). 13C NMR (75 MHz, CDCl3): δ
167.57 (C), 158.90 (C), 145.14 (C), 140.88 (C), 129.43 (CH), 126.61 (CH), 125.33 (CH), 120.90 
(CH), 111.81 (CH), 47.73 (C), 46.53 (CH2), 42.02 (br, N-CH2), 40.25 (br, N-CH2), 35.44 (CH2), 35.29 
(CH), 35.16 (CH2), 26.86 (CH3), 26.62 (CH2), 26.43 (CH2), 13.47 (CH3). HRMS (ESI-TOF): m/z 
calculated for C23H34NO ([M+H]+) 340.2634, found 340.2635. 
(E)-2-(2,2-Dimethyl-3,4-dihydronaphthalen-1(2H)-ylidene)-N,N-diethylacetamide (2o)
Carried out in refluxing dioxane. The product was isolated by flash 
chromatography (10 to 20 % EtOAc/ Hexanes) as an orange pale oil (92% yield) 
1H NMR (300 MHz, CDCl3): δ 7.53 – 7.47 (m, 1H), 7.22 – 7.14 (m, 2H), 7.14 –
7.08 (m, 1H), 6.23 (s, 1H), 3.43 (dq, J = 18.7, 7.1 Hz, 4H), 2.82 (t, J = 6.5 Hz, 
2H), 1.69 (t, J = 6.5 Hz, 2H), 1.26 (s, 6H), 1.20 – 1.11 (m, 6H). 13C NMR (75 
MHz, CDCl3): δ 169.44 (C), 148.62 (C), 137.87 (C), 136.47 (C), 128.46 (CH), 127.85 (CH), 126.27 
(CH), 126.20 (CH), 118.73 (CH), 42.78 (CH2), 39.20 (CH2), 38.77 (CH2), 36.35 (CH2), 29.81 (C), 
27.14 (CH3), 26.83 (CH2), 13.78 (CH3), 12.34 (CH3). HRMS (ESI-TOF): m/z calculated for C18H26NO 
([M+H]+) 272.2010, found 272.2009.
(E)-N,N-Diethyl-2-(3-ethyl-3-methylchroman-4-ylidene)acetamide (2p)
Carried out in refluxing dioxane. The product was isolated by flash 
chromatography (5 to 10 % EtOAc/Hexanes) as yellow oil (82 % yield). 1H NMR 
(300 MHz, CDCl3):  δ 7.48 (dd, J = 8.0, 1.6 Hz, 1H), 7.19 (ddd, J = 8.4, 7.2, 1.6 
Hz, 1H), 6.90 (ddd, J = 8.2, 7.2, 1.3 Hz, 1H), 6.83 (dd, J = 8.2, 1.3 Hz, 1H), 6.37 
(s, 1H), 3.94 (d, J = 11.1 Hz, 1H), 3.79 (d, J = 11.1 Hz, 1H), 3.62 – 3.41 (m, 2H), 
3.40 – 3.26 (m, 2H), 1.83 – 1.70 (m, 1H), 1.61 – 1.47 (m, 1H), 1.20 – 1.12 (m, 9H), 0.91 (t, J = 7.5 
Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 168.75 (C), 154.58 (C), 143.34 (C), 129.91 (CH), 125.72 
(CH), 121.46 (C), 121.03 (CH), 117.12 (CH), 116.35 (CH), 73.83 (CH2), 42.83 (CH2), 38.99 (CH2), 
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38.52 (C), 28.17 (CH2), 19.02 (CH3), 13.85 (CH3), 12.41 (CH3), 8.66 (CH3). HRMS (ESI-TOF): m/z 
calculated for C18H26NO2 ([M+H]+) 288.1959, found 288.1958.
(E)-N,N-Diethyl-2-(3-isobutyl-3-methylchroman-4-ylidene) acetamide (2q)
Carried out in refluxingdDioxane. The product was isolated by flash 
chromatography (5 to 10 % EtOAc/Hexanes) as yellow pale oil (90 %). 1H NMR 
(400 MHz, CDCl3):  δ 7.43 (dd, J = 8.0, 1.5 Hz, 1H), 7.22 – 7.17 (m, 1H), 6.93 –
6.87 (m, 1H), 6.82 (dd, J = 8.1, 1.3 Hz, 1H), 6.29 (s, 1H), 3.90 (d, J = 11.0 Hz, 
1H), 3.79 (d, J = 11.0 Hz, 1H), 3.63 – 3.53 (m, 1H), 3.52 – 3.41 (m, 1H), 3.37 –
3.25 (m, 2H), 1.98 – 1.87 (m, 1H), 1.67 (dd, J = 14.3, 6.6 Hz, 1H), 1.34 (dd, J = 14.2, 4.5 Hz, 1H), 
1.21 (s, 3H), 1.19 – 1.13 (m, 6H), 0.90 (d, J = 6.7 Hz, 3H), 0.82 (d, J = 6.6 Hz, 3H). 13C NMR (101 
MHz, CDCl3): δ 168.67 (C), 154.37 (C), 144.18 (C), 129.93 (CH), 126.08 (CH), 121.92 (C), 121.04 
(CH), 116.85 (CH), 116.59 (CH), 75.42 (CH2), 44.62 (CH2), 42.81 (CH2), 39.05 (CH2), 38.61 (C), 
25.52 (CH), 24.51 (CH3), 24.14 (CH3), 19.96 (CH3), 13.87 (CH3), 12.47 (CH3). HRMS (ESI-TOF):




Carried out in refluxing dioxane, the products were isolated by flash chromatography (5 to 20 % 
EtOAc/Hexanes) as dark brown oil [90% combined yield, E / Z = 1:1)] 
E-2r : NMR data of E-2r was deduced from a 3.9 : 1 E / Z sample of 2r, 
obtained after careful column chromatography. 1H NMR (400 MHz, 
CDCl3): δ 7.53 (d, J = 7.9 Hz, 1H), 7.21 – 7.17 (m, 1H), 7.10 (ddd, J = 8.2, 
6.9, 1.2 Hz, 1H), 7.02 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.47 (s, 2H), 4.12 (d, 
J = 10.1 Hz, 1H), 3.82 (d, J = 10.1 Hz, 1H), 3.44 – 3.30 (m, 4H), 2.07 (dd, J = 13.9, 6.3 Hz, 1H), 
1.75 (dd, J = 14.0, 6.0 Hz, 1H), 1.62 – 1.57 (m, 1H), 1.51 (s, 3H), 1.16 – 1.10 (m, 6H), 0.83 – 0.77 
(m, 6H). 13C NMR (101 MHz, CDCl3): δ 166.29 (C), 148.97 (C), 143.83 (C), 133.64 (C), 132.77 (C), 
121.95 (CH), 121.51 (CH), 120.23 (CH), 113.33 (CH), 109.96 (CH), 92.08 (CH), 56.64 (CH2), 51.80 
(C), 47.54 (CH2), 42.88 (CH2) 39.90 (CH2), 26.39 (CH), 25.77 (CH3), 24.69 (CH3), 24.38 (CH3), 
14.33 (CH3), 13.08 (CH3). HRMS (ESI-TOF): m/z calculated for C22H31N2O ([M+H]+) 339.2434, 
found 339.2431.
Z-2r: NMR data of Z-2r was deduced from a 1 : 3.5 E / Z sample of 2r, 
obtained after careful column chromatography. 1H NMR (400 MHz, CDCl3): δ 
7.55 (d, J = 8.1 Hz, 1H), 7.17 (d, J = 8.5 Hz, 1H), 7.10 (ddd, J = 8.2, 6.7, 1.1 
Hz, 1H), 7.04 (s, 1H), 6.99 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H), 5.86 (s, 1H), 4.06 (d, 
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J = 10.1 Hz, 1H), 3.80 (d, J = 10.1 Hz, 1H), 3.50 – 3.31 (m, 4H), 1.68 – 1.61 (m, 1H), 1.58 (t, J = 5.7 
Hz, 2H), 1.34 (s, 3H), 1.21 – 1.07 (m, 6H), 0.86 – 0.80 (m, 6H). 13C NMR (101 MHz, CDCl3): δ 
166.75 (C), 148.74 (C), 139.17 (C), 133.56 (C), 133.00 (C), 122.43 (CH), 122.33 (CH), 119.90 (CH), 
112.01 (CH), 109.71 (CH), 100.50 (CH), 54.13 (CH2), 51.78 (C), 50.42 (CH2), 42.91 (CH2), 40.24 
(CH2), 28.11 (CH), 25.44 (CH3), 25.01 (CH3), 24.76 (CH3), 14.80 (CH3), 13.45 (CH3). HRMS (ESI-




Carried out in refluxing Dioxane. The products were separately isolated by flash chromatography (5 
to 20 % EtOAc/Hexanes) [E-2s: 43 % yield and Z-2s: 43% yield)].
E-2s: 1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.0 Hz, 1H), 7.25 (d, J = 
7.7 Hz, 1H), 7.19 – 7.13 (m, 1H), 7.08 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 
6.55 (s, 1H), 6.52 (s, 1H), 4.09 (d, J = 10.1 Hz, 1H), 3.83 (d, J = 10.1 Hz, 
1H), 3.49 – 3.38 (m, 4H), 2.22 – 2.11 (m, 1H), 1.95 – 1.84 (m, 1H), 1.55 
(s, 3H), 1.22 – 1.15 (m, 6H), 0.83 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 166.34 (C), 
148.12 (C), 143.90 (C), 133.64 (C), 132.71 (C), 121.95 (CH), 121.50 (CH), 120.21 (CH), 113.57 
(CH), 109.94 (CH), 91.98 (CH), 55.35 (CH2), 52.15 (C), 42.91 (CH2), 39.85 (CH2), 31.57 (CH2), 
25.11 (CH3), 14.34 (CH3), 13.04 (CH3), 9.43 (CH3). HRMS (ESI-TOF): m/z calculated for C20H27N2O 
([M+H]+) 311.2118, found 311.2118; m/z calculated for C20H27N2ONa ([M+Na]+) 333.1941, found 
333.1937.
Z-2s: 1H NMR (400 MHz, CDCl3): δ 7.61 (d, J = 8.0 Hz, 1H), 7.22 (d, J = 9.1 
Hz, 1H), 7.16 (ddd, J = 8.1, 6.8, 1.1 Hz, 1H), 7.11 (s, 1H), 7.05 (ddd, J = 8.1, 
6.8, 1.2 Hz, 1H), 5.90 (s, 1H), 4.04 (d, J = 10.1 Hz, 1H), 3.83 (d, J = 10.1 Hz, 
1H), 3.55 – 3.50 (m, 2H), 3.43 – 3.36 (m, 2H), 1.72 (q, J = 7.4, 6.9 Hz, 2H), 
1.39 (s, 3H), 1.26 – 1.14 (m, 6H), 0.88 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, 
CDCl3): δ 166.74 (C), 148.13 (C), 139.35 (C), 133.59 (C), 132.96 (C), 122.44 (CH), 122.35 (CH), 
119.88 (CH), 111.88 (CH), 109.70 (CH), 100.47 (CH), 53.22 (CH2), 51.87 (C), 42.97 (CH2), 40.33 
(CH2), 34.40 (CH2), 26.82 (CH3), 14.81 (CH3), 13.47 (CH3), 9.15 (CH3). HRMS (ESI-TOF): m/z 
calculated for C20H27N2O ([M+H]+) 311.2116, found 311.2118.
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Control experiments related to the formation of E / Z isomers of 2r and 2s
Control experiments carried out for the cyclizations of 1r and 1s suggest that these mixtures are the 
result of an isomerization of the initially formed e-isomer (E- 2r , E-2s), presumably mediated by the 
Ir(I) catalyst (Scheme S1, eq. a). The isomerization is also observed during the isolation process in 
the contact to silica-gel (Scheme S1, eq. b). 
 
Scheme S1. Isomerization experiments of 2s.
N,N-Diethyl-3,3-dimethyl-2,3-dihydrobenzofuran-4-carboxamide (6a)
Carried out in refluxing dioxane. The product was isolated by flash chromatography 
(5 to 10 % EtOAc/Hexanes) as yellow oil (82 % yield). 1H NMR (500 MHz, CDCl3):  
δ 7.12 (td, J = 7.8, 2.6 Hz, 1H), 6.79 (dd, J = 8.0, 2.6 Hz, 1H), 6.69 (dd, J = 7.5, 2.6 
Hz, 1H), 4.25 – 4.21 (m, 1H), 4.17 – 4.13 (m, 1H), 4.03 – 3.96 (m, 1H), 3.21 – 3.03 
(m, 3H), 1.40 (s, 3H), 1.28 (s, 3H), 1.24 – 1.19 (m, 3H), 1.09 – 1.04 (m, 3H). 13C NMR (126 MHz, 
CDCl3): δ 169.31 (C), 159.56 (C), 133.01 (C), 131.05 (C), 128.52 (CH), 117.57 (CH), 110.30 (CH), 
84.44 (CH2), 42.70 (CH2), 42.64 (C), 38.01 (CH2), 27.54 (CH3), 24.31 (CH3), 13.76 (CH3), 12.34 
(CH3). HRMS (ESI-TOF): m/z calculated for C15H21NO2 ([M+H]+) 248.1644, found 248.1645.
N,N,3-Triethyl-3-methyl-2,3-dihydrobenzofuran-4-carboxamide (6b)
Carried out in refluxing dioxane. The product was isolated by flash 
chromatography (5 to 10 % EtOAc/Hexanes) as yellow oil (92 % yield). 1H NMR 
(400 MHz, CDCl3): 1H NMR (300 MHz, CDCl3, at 60 ºC): δ 7.09 (td, J = 7.8, 1.6 
Hz, 1H), 6.75 (dd, J = 8.1, 0.7 Hz, 1H), 6.65 (dd, J = 7.6, 0.8 Hz, 1H), 4.34 (d, J = 
8.5 Hz, 1H), 4.08 (d, J = 8.5 Hz, 1H), 3.54 (br, 2H), 3.23 – 3.09 (m, 2H), 1.89 – 1.60 (m, 2H), 1.34 
(s, 3H), 1.28 – 1.21 (m, 3H), 1.15 – 1.06 (m, 3H), 0.81 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3, 
at 60 ºC): δ 169.59 (C), 160.89 (C), 134.02 (C), 131.07 (C), 128.23 (CH), 118.27 (CH), 110.16 (CH), 
82.06 (CH2), 46.98 (C), 43.25 (CH), 38.67 (CH2), 32.37 (CH2), 24.55 (CH2), 13.94 (CH3), 12.64 




Carried out in refluxing dioxane. The product was isolated by flash chromatography 
(10 to 30 % EtOAc/Hexanes) as light brown solid (95% yield) 1H NMR (300 MHz, 
CDCl3): δ 6.38 (d, J = 2.8 Hz, 1H), 6.16 (d, J = 2.8 Hz, 1H), 3.92 (t, J = 6.9 Hz, 2H), 
3.49 (q, J = 7.1 Hz, 4H), 2.28 (t, J = 6.9 Hz, 2H), 1.40 (s, 6H), 1.17 (t, J = 7.1 Hz, 6H). 13C NMR (75 
MHz, CDCl3): δ 167.85 (C), 146.94 (C), 112.15 (CH), 111.39 (CH), 109.94 (C), 45.16 (CH2), 44.78 
(CH2), 41.42 (CH2), 39.68 (C), 26.92 (CH3), 13.86 (CH3). HRMS (ESI-TOF): m/z calculated for 
C14H23N2O ([M+H]+) 235.1805, found  235.1805.
N,N-Diethyl-1,1-dimethyl-2,3-dihydro-1H-pyrrolo[1,2-a]indole-9-carboxamide (6d)
Carried out in 1,2-DCE at 140 ºC. The product was isolated by flash 
chromatography (10 to 20 % EtOAc/ Hexanes) as a pale yellow oil (99% yield).
1H NMR (500 MHz, CDCl3): δ 7.40 (dt, J = 7.8, 1.1 Hz, 1H), 7.22 (dt, J = 8.0, 1.1 
Hz, 1H), 7.16 – 7.12 (m, 1H), 7.12 – 7.07 (m, 1H), 4.10 (t, J = 6.8 Hz, 2H), 3.62 –
3.45 (m, 4H), 2.44 – 2.41 (m, 2H), 1.50 (s, 6H), 1.22 – 1.11 (m, 6H). 13C NMR (126 MHz, CDCl3): δ 
167.42 (C), 152.91 (C), 131.29 (C), 129.99 (C), 121.03 (CH), 120.07 (CH), 119.73 (CH), 109.76 
(CH), 102.67 (C), 44.31 (CH2), 42.69 (CH2), 39.58 (C), 27.02 (CH3), 14.00 (CH3). HRMS (ESI-TOF):
m/z calculated for C18H25N2O ([M+H]+) 285.1961, found 285.1961. {NOTE: This compound was also 
characterized at 60 ºC in CDCl3, in order to more clearly show the amide carbons, which sometimes 
are not fully visible at rt due to the existence of rotamers. 1H NMR (300 MHz, CDCl3) δ 7.41 (dd, J = 
8.0, 1.5 Hz, 1H), 7.23 – 7.19 (m, 1H), 7.17 – 7.06 (m, 2H), 4.09 (t, J = 6.9 Hz, 2H), 3.55 (q, J = 7.1 
Hz, 4H), 2.43 (t, J = 7.0 Hz, 2H), 1.51 (s, 6H), 1.18 (t, J = 7.1 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ
167.51 (C), 152.87 (C), 131.57 (C), 130.32 (C), 121.13 (CH), 120.18 (CH), 119.86 (CH), 109.78 
(CH), 103.10 (C), 44.52 (CH2), 42.71 (CH2), 41.30 (CH2), 39.67 (C), 27.15 (CH3), 13.99 (CH3). 
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Assays for the development of an enantioselective version
Table S2. Preliminary screening of an asymmetric catalyst for the hydrocarbonation of 1a.[a]
entry L X Solvent Temp (ºC) time (h) Yield (%) er 
1 L1 BArF dioxane reflux 19 40 88 : 12
2 L2 BArF dioxane reflux 19 72 84 : 16
3 L3 BArF dioxane reflux 19 74 79 : 21
4 L4 BArF dioxane reflux 19 65 68 : 32
5 L5 BArF dioxane reflux 19 70 51 : 49
6 L6 BArF dioxane reflux 19 40 59: 41
7 L7 BArF dioxane reflux 19 99 56 : 44
8 L8 BArF dioxane reflux 19 68 65 : 35
9 L9 BArF dioxane reflux 19 61 52 : 48
10 L1 BArF dioxane 80 19 34 90 : 10
11[c] L2 BArF dioxane 80 19 30 85 :1 5
12 L3 BArF dioxane 80 19 80 82 : 18 
13[b] L1 BF4 dioxane 80 48 95 80 : 20
14[b] L3 BF4 dioxane 80 19 90 91 : 9 
15[b] L3 BF4 1,2-DCE 60 7 70 87 : 13
16[d] L3 BF4 CH2Cl2 50 19 95 89 : 11
[a] 1a was added to a solution of [Ir(cod)2X] (5 %) and L (5 %) in the solvent (125 mM) and the mixture 
was heated at the indicated temperature. Isolated yields. [b] Carried out at 250 mM (1a). [c] 67% 
conversion. [d] In a sealed tube.
Conditions for the determination of the er of 2a and HPLC traces of all entries of Table S2
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(Z)-2-(2-Butyl-2-methylcyclopentylidene)-N,N-diethylacetamide (2a). 
Enantiomeric ratios determined by chiral HPLC on Chiralpak IF3 at rt, (Hexane : 
iPrOH = 98:2, 1 ml/min).
Figure S1. HPLC trace and report of a racemic sample of 2a [Chiralpak IF3 at rt, (Hexane : iPrOH = 
98:2, 1 ml/min)]
Figure S2. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L1 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 1.
Figure S3. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L2 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 2.
Figure S4. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L3 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 3.
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Figure S5. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L4 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 4.
Figure S6. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L5 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 5.
Figure S7. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L6 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 6.
Figure S8. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L7 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 7.
Figure S9. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L8 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 8.
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Figure S10. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L9 at reflux (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 9.
Figure S11. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L1 at 80 ºC (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 
10.
Figure S12. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L2 at 80 ºC (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 
11.
Figure S13. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BArF / L3 at 80 ºC (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 
12.
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Figure S14. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / L1 at 80 ºC (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table S2, entry 13.
Figure S15 HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / L3 at 60 ºC in 1,2-DCE (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table 
S2, entry 15, Supporting information.
Figure S16. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / L3 at 50 ºC in CH2Cl2 (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table 
S2, entry 16, Supporting information.
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Procedure for the enantioselective Ir-catalyzed intramolecular hydrocarbonation process
An oven dried schlenk tube equipped with a Teflon septum and magnetic stir bar was charged with 
L1 or L3 (5 mol%), Bis(1,5-cyclooctadiene)iridium(I) tetrafluoroborate (5 mol%), the amide substrate 
(1.0 equiv) and the solvent (dioxane or 1,2-DCE, 0.250 M). The reaction mixture was then stirred at 
80 °C. After TLC indicated full conversion of the starting material, the reaction mixture was 
concentrated in vacuo. Purification of the crude product by flash chromatography on silica gel 
(typically 1:20 to 1:10 EtOAc : hexanes) afforded the desired product.
(Z)-2-(2-Butyl-2-methylcyclopentylidene)-N,N-diethylacetamide (2a)
Using the general procedure, dioxane and L3, (Z)-2-(2-butyl-2-
methylcyclopentylidene)-N,N-diethylacetamide (2a) was obtained in 90 % yield and 
91:9 er. Enantioselectivity was determined by chiral HPLC analysis on Chiralpak IF3 
at rt, (Hexane : iPrOH = 98:2, 1 ml/min).
Figure S17. HPLC trace and report of a racemic sample of 2a [Chiralpak IF3 at rt, (Hexane : iPrOH 
= 98:2, 1 ml/min)]
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Figure S18. HPLC trace and report of a sample of 2a obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / L3 (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table 4, entry 5, main 
manuscript or Table S2, entry 14.
(Z)-N,N-Diethyl-2-(2-isobutyl-2-methylcyclopentylidene)acetamide (2e)
Using the general procedure, 1,2-DCE and L3, (Z)-N,N-diethyl-2-(2-isobutyl-2-
methylcyclopentylidene)acetamide (2e) was obtained in 82 % yield and 91:9 er.
Enantioselectivity was determined by chiral HPLC analysis on Chiralpak IF3 at rt, 
(Hexane : iPrOH = 99:1, 1 ml/min).
Figure S19. HPLC trace and report of a racemic sample of 2e [Chiralpak IF3 at rt, (Hexane : iPrOH 
= 99:1, 1 ml/min)]
Figure S20. HPLC trace and report of a sample of 2e obtained from the reaction catalyzed by 




Using the general procedure, dioxane and L1 (10 mol%), (Z)-2-(2-benzyl-2-
methylcyclopentylidene)-N,N-diethylacetamide (2g) was obtained after 48 hours in 81 
% yield and 83:17 er. Enantioselectivity was determined by chiral HPLC analysis on 
Chiralpak IF3 at rt, (Hexane : iPrOH = 98:2, 1 ml/min).
Figure S21. HPLC trace and report of a racemic sample of 2g [Chiralpak IF3 at rt, (Hexane : iPrOH 
= 98:2, 1 ml/min)]
Figure S22. HPLC trace and report of a sample of 2g obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / L1 (Chiralpak IF3 at rt, Hexane : iPrOH = 98:2, 1 ml/min). Table 4, entry 9, main 
manuscript.
(E)-2-(2-Butyl-2-methyl-2,3-dihydro-1H-inden-1-ylidene)-N,N-diethylacetamide (2l)
Using the general procedure, dioxane and DM-SDP (L1, 10 %), (E)-2-(2-butyl-
2-methyl-2,3-dihydro-1H-inden-1-ylidene)-N,N-diethylacetamide (2l) was 
obtained after 48 hours in 98 % yield and 82:18 er. Enantioselectivity was 
determined by chiral HPLC analysis on Chiralpak IF3 at rt, (Hexane : iPrOH = 
99:1, 1 ml/min). Note: In this reaction, DM-SDP (L1) proved to be superior to BTFM-Garphos, which 
provided the product 2l in 95% yield and 61:39 er (5% catalyst, dioxane, 80 ºC for 19 h)}.
Figure S23. HPLC trace and report of a racemic sample of 2l [Chiralpak IF3 at rt, (Hexane : iPrOH 
= 99:1, 1 ml/min)]
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Figure S24. HPLC trace and report of a sample of 2l obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / L1 (Chiralpak IF3 at rt, Hexane : iPrOH = 99:1, 1 ml/min). Table 4, entry 10, main 
manuscript.
Figure S25. HPLC trace and report of a sample of 2l obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / BTFM-Garphos (Chiralpak IF3 at rt, Hexane : iPrOH = 99:1, 1 ml/min).
(E)-N,N-Diethyl-2-(2-isobutyl-2-methyl-2,3-dihydro-1H-inden-1-ylidene)acetamide (2m)
Using the general procedure, dioxane and DM-SDP (L1, 10 %), (E)-N,N-
diethyl-2-(2-isobutyl-2-methyl-2,3-dihydro-1H-inden-1-ylidene)acetamide (2m) 
was obtained after 48 hours in 95 % yield and 91:9 er. Enantioselectivity was 
determined by chiral HPLC analysis on Chiralpak IF3 at rt, (Hexane : iPrOH = 
99:1, 1 ml/min). {Note: In this reaction, DM-SDP (L1) proved to be superior to BTFM-Garphos, 
which provided the product 2m in 90% yield and 71:29 er (5% catalyst, dioxane, 80 ºC for 19 h)}. 
 
Figure S26. HPLC trace and report of a racemic sample of 2m [Chiralpak IF3 at rt, (Hexane : iPrOH 
= 99:1, 1 ml/min)]
Figure S27. HPLC trace and report of a sample of 2m obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / L1 (Chiralpak IF3, rt, Hex.: iPrOH = 99:1, 1 ml/min). Table 4, entry 11, main 
manuscript.
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Figure S28. HPLC trace and report of a sample of 2m obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / BTFM-Garphos (L3) (Chiralpak IF3 at rt, Hexane : iPrOH = 99:1, 1 ml/min).
(E)-2-(2-(Cyclohexylmethyl)-2-methyl-2,3-dihydro-1H-inden-1-ylidene)-N,N-diethylacetamide
(2n)
Using the general procedure, dioxane and DM-SDP (L1, 10 %), (E)-2-(2-
(cyclohexylmethyl)-2-methyl-2,3-dihydro-1H-inden-1-ylidene)-N,N-
diethylacetamide (2n) was obtained after 48 hours in 90 % yield and 86:14 er.
Enantioselectivity was determined by chiral HPLC analysis on Chiralpak IF3 at 
rt, (Hexane : iPrOH = 99:1, 1 ml/min). {Note: In this reaction, DM-SDP (L1) proved to be superior to 
BTFM-Garphos, which provided the product 2n in 85% yield and a 66:34 er (5 mol% catalyst, 
Dioxane, 80 ºC for 19 h)}.
Figure S29. HPLC trace and report of a racemic sample of 2n [Chiralpak IF3 at rt, (Hexane : iPrOH 
= 99:1, 1 ml/min)]
Figure S30. HPLC trace and report of a sample of 2n obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / L1 (Chiralpak IF3 at rt, Hexane : iPrOH = 99:1, 1 ml/min). Table 4, entry 12, main 
manuscript.
Figure S31. HPLC trace and report of a sample of 2n obtained from the reaction catalyzed by 
[Ir(cod)2]BF4 / BTFM-Garphos (L3). 
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Determination of the Kinetic Isotope effect
In two different Schlenk flasks equipped with their respective stirring bars, Ir(cod)2BArF (24.7 mg, 
0.019 mmol), dppFe (14.7 mg, 0.019 mmol) and 1k (100 mg, 0.389 mmol, Schlenk 1) or 1k’ (101 
mg, 0.389 mmol, Schlenk 2), were successively added under Argon. Dioxane (1.6 mL, each one) 
was then added and the flasks were sealed with rubber septa and placed in a pre-heated (70 °C) oil 
bath. Aliquots (300 L) were taken at the times indicated in the Table S3 (for 1k) and Table S4 (for 
1k’). The aliquots were filtered through a florisil pad and the volatiles were removed so that the the 
crude residues were taken and analyzed by 1H NMR.
Table S3. Conversions observed from the reaction of 1k (determined by 1H-NMR analysis). 
 





















rate experiment for 1k and 1k'
1k
1k'
y = 0,8x - 2,5
R² = 0,98765
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Table S4. Conversions observed from the reaction of 1k’ (determined by 1H-NMR analysis)..






Transformation of the products into the corresponding ketone derivatives. 
Synthesis of ketones 7a, 7g, 7m and 7q (exemplified for 7a).
2-Butyl-2-methylcyclopentan-1-one (7a)
A solution of NaIO4 (89.3 mg, 0.42 mmol) in water (0.7 mL, 0.17 M) was added to a 
solution of RuCl3 (3.7 mg, 0.018 mmol) in MeCN (0.9 mL, 0.13 M). This mixture was 
stirred 2 minutes and then a solution of the 2a (30 mg, 0.12 mmol) in EtOAc (0.9 mL, 
0.13 M) was added. The mixture was stirred for 5-10 minutes until TLC indicates complete 
consumption of the starting material. MgSO4 was added and the resulting heterogeneous mixture 
was washed with EtOAc. The combined organic phases were carefully evaporated and the crude 
residue was purified by column chromatography (1:10 Et2O : Pentane) to yield 7a as a colorless oil 
(17 mg, 93% yield). 1H NMR (500 MHz, CDCl3): δ 2.32 – 2.13 (m, 2H), 1.93 – 1.82 (m, 3H), 1.73 –
1.63 (m, 1H), 1.42 – 1.23 (m, 5H), 1.17 – 1.07 (m, 1H), 0.98 (s, 3H), 0.88 (t, J = 7.0 Hz, 3H). 13C 
NMR (126 MHz, CDCl3): δ 223.95 (C), 48.43 (C), 37.85 (CH2), 36.57 (CH2), 35.81 (CH2), 26.63 
(CH2), 23.43 (CH2), 21.99 (CH3), 18.85 (CH2), 14.12 (CH3). HRMS (APCI-FIA-TOF): m/z calculated 
for C10H19O ([M+H]+) 155.1431, found 155.1430.
2-Benzyl-2-methylcyclopentan-1-one (7g) 
Colorless oil, 85% yield. 1H NMR (500 MHz, CDCl3): δ 7.21 – 7.17 (m, 2H), 7.16 – 7.11 
(m, 1H), 7.05 – 7.02 (m, 2H), 2.79 (d, J = 13.3 Hz, 1H), 2.52 (d, J = 13.3 Hz, 1H), 2.22 
(ddd, J = 18.9, 8.4, 5.3 Hz, 1H), 1.98 (dt, J = 19.0, 8.6 Hz, 1H), 1.89 (dt, J = 13.0, 7.6 
Hz, 1H), 1.76 – 1.62 (m, 2H), 1.59 – 1.53 (m, 1H), 0.95 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 
223.39 (C), 138.12 (C), 130.38 (CH), 128.26 (CH), 126.50 (CH), 49.89 (C), 42.81 (CH2), 38.13 
y’ = 0,4407x’ - 2,822
R² = 0,97263
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(CH2), 34.79 (CH2), 22.84 (CH3), 18.75 (CH2). HRMS (ESI-TOF): m/z calculated for C13H16NaO 
([M+Na]+) 211.1091, found 211.1093.
2-Isobutyl-2-methyl-2,3-dihydro-1H-inden-1-one (7m) 
 Colorless oil, 66% yield. 1H NMR (400 MHz, CDCl3):δ 7.76 (d, J = 7.6 Hz, 1H), 
7.58 (td, J = 7.5, 1.2 Hz, 1H), 7.43 (dt, J = 7.7, 1.0 Hz, 1H), 7.39 – 7.34 (m, 1H), 
3.21 (d, J = 17.2 Hz, 1H), 2.88 (d, J = 17.2 Hz, 1H), 1.69 – 1.61 (m, 2H), 1.59 –
1.50 (m, 1H), 1.19 (s, 3H), 0.90 (d, J = 6.4 Hz, 3H), 0.78 (d, J = 6.5 Hz, 3H). 13C NMR (101 MHz, 
CDCl3): δ 211.70 (C), 152.82 (C), 136.06 (C), 134.85 (CH), 127.50 (CH), 126.70 (CH), 124.46 (CH), 
49.25 (C), 46.57 (CH2), 40.61 (CH2), 25.48 (C), 25.33 (CH3), 24.94 (CH3), 23.75 (CH3). HRMS (ESI-
TOF): m/z calculated for C14H19O ([M+H]+) 203.1430, found 203.1430.
3-Isobutyl-3-methylchroman-4-one (7q) 
 Colorless oil, 87% yield. 1H NMR (400 MHz, CDCl3): δ 7.89 (dd, J = 7.9, 1.8 Hz, 
1H), 7.46 (ddd, J = 8.4, 7.2, 1.8 Hz, 1H), 7.02 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 6.95 
(dd, J = 8.4, 1.1 Hz, 1H), 4.27 (d, J = 11.5 Hz, 1H), 4.13 (d, J = 11.5 Hz, 1H), 1.77 
– 1.67 (m, 1H), 1.61 (dd, J = 6.0, 2.1 Hz, 2H), 1.18 (s, 3H), 0.93 (d, J = 6.6 Hz, 3H), 0.83 (d, J = 6.5 
Hz, 3H). 13C NMR (101 MHz, CDCl3): 197.41 (C), 161.12 (C), 135.56 (CH), 127.92 (CH), 121.56 
(CH), 120.15 (C), 117.66 (CH), 75.62 (CH2), 45.19 (CH), 42.86 (CH2), 24.82 (CH3), 24.69 (CH3), 
24.34 (CH), 18.70 (CH3). HRMS (ESI-TOF): m/z calculated for C14H19O2 ([M+H]+) 219.1378, found 
219.1380.
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Cycloisomerization of 1t to afford the isomerized indene product 2t’
Carried out following the general procedure, in Dioxane at reflux for 19 h. The product (2t’) was 
isolated by flash chromatography (5 to 10 % EtOAc/Hexanes) as a pale 
yellow oil (99 % yield). (E)-N,N-Diethyl-2-(2-methyl-2-(3-methylbut-2-en-1-
yl)-2,3-dihydro-1H-inden-1-ylidene) acetamide (2t’) 1H NMR (300 MHz, 
CDCl3): δ 7.46 (dd, J = 8.1, 1.6 Hz, 1H), 7.29 – 7.17 (m, 3H), 6.44 (s, 1H), 
5.09 – 5.02 (m, 1H), 3.51 – 3.32 (m, 4H), 3.04 (d, J = 16.4 Hz, 1H), 2.65 (d, J
= 16.4 Hz, 1H), 2.61 – 2.43 (m, 2H), 1.63 (s, 3H), 1.59 (s, 3H), 1.40 (s, 3H), 
1.21 – 1.13 (m, 6H). 13C NMR (75 MHz, CDCl3): δ 167.61 (C), 157.90 (C), 145.09 (C), 140.87 (C), 
133.33 (C), 129.41 (CH), 126.60 (CH), 125.43 (CH), 121.54 (CH), 120.98 (CH), 112.22 (CH), 48.21 
(C), 45.15 (CH2), 42.83 (CH2), 39.46 (CH2), 36.95 (CH2), 26.02 (CH3), 18.24 (CH3), 14.09 (CH3), 
12.92 (CH3). HRMS (ESI-TOF): m/z calculated for C21H30NO ([M+H]+) 312.2322, found 312.2322. 
Assignment of structure of 2t’ was based on the HMBC, HSQC, COSY and nOe experiments.
Figure S1. Significant nOe signals observed for 2t’
The following control experiments, carrying out the cyclization of 1t at lower temperatures indicate 
that the observed isomerization of the pendant double bond occurs in the reaction media, after the 
initial formation of the expected, non-isomerized, product 2t.
Table S3. Control experiments related to the cycloisomerization of 1t (ref. 21, main manuscript)
entry Temperature time (h) Conversion 2t (%) 2t’ (%)
1 60 ºC 1 55% 55 -
2 100 ºC 1 70% 20 50
3 100 ºC 18 100% - 99
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Mechanistic probe: NMR spectra of D-2t’, resulting from the cycloaddition of D-1t (related to 
Scheme 3, eq. 2, main manuscript)
As can be seen in the following Figures, deuteration of D-2t’ is only observed at the methyl group of 
the quaternary stereocenter (signal at 1.40 ppm). While in 2t’ the signal for this methyl group 
integrates for 3H, that of D-2t’ corresponds to 2H. Accordingly, 2H-NMR spectra of D-2t’ shows that 
deuterium is only located at this particular methyl group (1.40 ppm).
1H-NMR
2H-NMR








Figure S15. Amplified NMR window between 1.8 and 0.9 ppm (2t’ and D-2t’)
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